Contribution	O
of	O
NF-kappa	B-protein
B	I-protein
and	O
Sp1	B-DNA
binding	I-DNA
motifs	I-DNA
to	O
the	O
replicative	O
capacity	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
:	O
distinct	O
patterns	O
of	O
viral	O
growth	O
are	O
determined	O
by	O
T-cell	B-cell_type
types	I-cell_type
.	O

Starting	O
with	O
a	O
replication-incompetent	O
molecular	O
clone	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
,	O
lacking	O
all	O
the	O
NF-kappa	B-DNA
B	I-DNA
and	I-DNA
Sp1	I-DNA
binding	I-DNA
sites	I-DNA
present	O
in	O
the	O
native	B-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
(	O
LTR	B-DNA
)	O
,	O
proviruses	O
containing	O
reconstructed	B-DNA
LTRs	I-DNA
with	O
individual	O
or	O
combinations	O
of	O
NF-kappa	B-DNA
B	I-DNA
and	I-DNA
Sp1	I-DNA
elements	I-DNA
were	O
generated	O
and	O
evaluated	O
for	O
their	O
capacity	O
to	O
produce	O
virus	O
progeny	O
following	O
transfection-cocultivation	O
.	O

Virus	O
stocks	O
obtained	O
from	O
these	O
experiments	O
exhibited	O
a	O
continuum	O
of	O
replicative	O
capacities	O
in	O
different	O
human	B-cell_type
T-cell	I-cell_type
types	I-cell_type
depending	O
on	O
which	O
element	B-DNA
(	O
s	O
)	O
was	O
present	O
in	O
the	O
LTR	B-DNA
.	O

For	O
example	O
,	O
in	O
experiments	O
involving	O
proviral	O
clones	O
with	O
LTRs	B-DNA
containing	O
one	O
or	O
two	O
NF-kappa	B-DNA
B	I-DNA
elements	I-DNA
(	O
and	O
no	O
Sp1	B-DNA
binding	I-DNA
sites	I-DNA
)	O
,	O
a	O
hierarchy	O
of	O
cellular	O
permissivity	O
to	O
virus	O
replication	O
(	O
peripheral	B-cell_type
blood	I-cell_type
lymphocytes	I-cell_type
=	O
MT4	B-cell_line
greater	O
than	O
H9	B-cell_line
greater	O
than	O
CEM	B-cell_line
greater	O
than	O
Jurkat	B-cell_line
)	O
was	O
observed	O
.	O

Of	O
note	O
was	O
the	O
associated	O
emergence	O
of	O
second-site	B-DNA
LTR	I-DNA
revertants	O
which	O
involved	O
an	O
alteration	O
of	O
the	O
TATA	B-DNA
box	I-DNA
.	O

These	O
results	O
suggest	O
that	O
the	O
human	B-DNA
immunodeficiency	I-DNA
virus	I-DNA
type	I-DNA
1	I-DNA
LTR	I-DNA
possesses	O
functional	O
redundancy	O
which	O
ensures	O
virus	O
replication	O
in	O
different	O
T-cell	B-cell_type
types	I-cell_type
and	O
is	O
capable	O
of	O
changing	O
depending	O
on	O
the	O
particular	O
combination	O
of	O
transcriptional	B-protein
factors	I-protein
present	O
.	O

JournaAt	NULL
or	NULL
ViroLOGY	NULL
,	NULL
Aug.	NULL
1991	NULL
,	NULL
p.	NULL
4350-4358	NULL
0022-538	NULL
X/91/084350-09	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
©	NULL
1991	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

65	NULL
,	NULL
No	NULL
.	NULL

8	NULL
Contribution	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Spl	NULL
Binding	NULL
Motifs	NULL
to	NULL
the	NULL
Replicative	NULL
Capacity	NULL
of	NULL
Human	NULL
Immunodeficiency	NULL
Virus	NULL
Type	NULL
1	NULL
:	NULL
Distinct	NULL
Patterns	NULL
of	NULL
Viral	NULL
Growth	NULL
Are	NULL
Determined	NULL
by	NULL
T-Cell	NULL
Types	NULL
ELIZABETH	NULL
K.	NULL
ROSS	NULL
,	NULL
*	NULL
ALICIA	NULL
J.	NULL
BUCKLER-WHITE	NULL
,	NULL
``	NULL
ARNOLD	NULL
B.	NULL
RABSON	NULL
,	NULL
't	NULL
GEORGE	NULL
ENGLUND	NULL
,	NULL
!	NULL

AND	NULL
MALCOLM	NULL
A.	NULL
MARTIN'*	NULL
Laboratory	NULL
of	NULL
Molecular	NULL
Microbiology	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Diseases	NULL
,	NULL
Bethesda	NULL
,	NULL
Maryland	NULL
20892	NULL
,	NULL
``	NULL
and	NULL
Division	NULL
of	NULL
Molecular	NULL
Virology	NULL
and	NULL
Immunology	NULL
,	NULL
Georgetown	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Rockville	NULL
,	NULL
Maryland	NULL
20854	NULL
``	NULL
Received	NULL
13	NULL
February	NULL
1991/Accepted	NULL
9	NULL
May	NULL
1991	NULL
Starting	NULL
with	NULL
a	NULL
replication-incompetent	NULL
molecular	NULL
clone	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
,	NULL
lacking	NULL
all	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Spl	NULL
binding	NULL
sites	NULL
present	NULL
in	NULL
the	NULL
native	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
,	NULL
proviruses	NULL
containing	NULL
reconstructed	NULL
LTRs	NULL
with	NULL
individual	NULL
or	NULL
combinations	NULL
of	NULL
and	NULL
Sp1	NULL
elements	NULL
were	NULL
generated	NULL
and	NULL
evaluated	NULL
for	NULL
their	NULL
capacity	NULL
to	NULL
produce	NULL
virus	NULL
progeny	NULL
following	NULL
transfection-cocultivation	NULL
.	NULL

Virus	NULL
stocks	NULL
obtained	NULL
from	NULL
these	NULL
experiments	NULL
exhibited	NULL
a	NULL
continuum	NULL
of	NULL
replicative	NULL
capacities	NULL
in	NULL
different	NULL
human	NULL
T-cell	NULL
types	NULL
depending	NULL
on	NULL
which	NULL
element	NULL
(	NULL
s	NULL
)	NULL
was	NULL
present	NULL
in	NULL
the	NULL
LTR	NULL
.	NULL

For	NULL
example	NULL
,	NULL
in	NULL
experiments	NULL
involving	NULL
proviral	NULL
clones	NULL
with	NULL
LTRs	NULL
containing	NULL
one	NULL
or	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
elements	NULL
(	NULL
and	NULL
no	NULL
Spl	NULL
binding	NULL
sites	NULL
)	NULL
,	NULL
a	NULL
hierarchy	NULL
of	NULL
cellular	NULL
permissivity	NULL
to	NULL
virus	NULL
replication	NULL
(	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
=	NULL
MT4	NULL
>	NULL
H9	NULL
>	NULL
CEM	NULL
>	NULL
Jurkat	NULL
)	NULL
was	NULL
observed	NULL
.	NULL

Of	NULL
note	NULL
was	NULL
the	NULL
associated	NULL
emergence	NULL
of	NULL
second-site	NULL
LTR	NULL
revertants	NULL
which	NULL
involved	NULL
an	NULL
alteration	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
LTR	NULL
possesses	NULL
functional	NULL
redundancy	NULL
which	NULL
ensures	NULL
virus	NULL
replication	NULL
in	NULL
different	NULL
T-cell	NULL
types	NULL
and	NULL
is	NULL
capable	NULL
of	NULL
changing	NULL
depending	NULL
on	NULL
the	NULL
particular	NULL
combination	NULL
of	NULL
transcriptional	NULL
factors	NULL
present	NULL
.	NULL

The	NULL
retroviral	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
,	NULL
generated	NULL
during	NULL
the	NULL
early	NULL
phase	NULL
of	NULL
virus	NULL
infection	NULL
by	NULL
reverse	NULL
transcription	NULL
,	NULL
contains	NULL
several	NULL
cis-acting	NULL
elements	NULL
that	NULL
influence	NULL
viral	NULL
gene	NULL
expression	NULL
.	NULL

These	NULL
include	NULL
the	NULL
transcriptional	NULL
promoter	NULL
and	NULL
start	NULL
site	NULL
,	NULL
the	NULL
polyadenylation	NULL
signal	NULL
and	NULL
addition	NULL
site	NULL
,	NULL
and	NULL
binding	NULL
motifs	NULL
for	NULL
transcriptional	NULL
activators	NULL
.	NULL

In	NULL
some	NULL
retroviral	NULL
subfamilies	NULL
,	NULL
the	NULL
LTR	NULL
also	NULL
contains	NULL
targets	NULL
for	NULL
virus-encoded	NULL
transactivator	NULL
proteins	NULL
.	NULL

During	NULL
the	NULL
past	NULL
few	NULL
years	NULL
,	NULL
the	NULL
structure	NULL
and	NULL
function	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
LTR	NULL
has	NULL
been	NULL
intensively	NULL
investigated	NULL
.	NULL

Regulatory	NULL
motifs	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
Spl	NULL
,	NULL
TATA	NULL
)	NULL
have	NULL
been	NULL
identified	NULL
which	NULL
bind	NULL
cellular	NULL
proteins	NULL
that	NULL
are	NULL
constitutively	NULL
expressed	NULL
in	NULL
most	NULL
cells	NULL
(	NULL
7	NULL
,	NULL
11	NULL
,	NULL
20	NULL
)	NULL
;	NULL
these	NULL
sequences	NULL
appear	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
basal-level	NULL
HIV	NULL
gene	NULL
expression	NULL
.	NULL

Other	NULL
LTR	NULL
elements	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
NF-kB	NULL
and	NULL
NFAT-1	NULL
)	NULL
may	NULL
interact	NULL
with	NULL
factors	NULL
synthesized	NULL
only	NULL
in	NULL
activated	NULL
T	NULL
lymphocytes	NULL
(	NULL
6	NULL
,	NULL
21	NULL
,	NULL
28	NULL
,	NULL
37	NULL
)	NULL
,	NULL
thereby	NULL
limiting	NULL
vigorous	NULL
virus	NULL
replication	NULL
to	NULL
a	NULL
small	NULL
subset	NULL
of	NULL
circulating	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
PBLs	NULL
)	NULL
in	NULL
vivo	NULL
.	NULL

Still	NULL
other	NULL
regions	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
TAR	NULL
)	NULL
are	NULL
unique	NULL
to	NULL
HIV	NULL
and	NULL
are	NULL
required	NULL
for	NULL
high	NULL
levels	NULL
of	NULL
LTR-directed	NULL
gene	NULL
activity	NULL
(	NULL
4	NULL
,	NULL
8	NULL
,	NULL
13	NULL
,	NULL
18	NULL
,	NULL
36	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
interaction	NULL
of	NULL
virus-encoded	NULL
(	NULL
3	NULL
,	NULL
40	NULL
)	NULL
and	NULL
cellular	NULL
regulatory	NULL
proteins	NULL
with	NULL
one	NULL
another	NULL
and	NULL
with	NULL
the	NULL
HIV	NULL
LTR	NULL
in	NULL
both	NULL
resting	NULL
and	NULL
activated	NULL
human	NULL
lymphocytes	NULL
has	NULL
the	NULL
potential	NULL
to	NULL
effect	NULL
a	NULL
continuum	NULL
of	NULL
replicative	NULL
capacities	NULL
.	NULL

To	NULL
date	NULL
,	NULL
most	NULL
of	NULL
our	NULL
knowledge	NULL
of	NULL
HIV	NULL
LTR	NULL
structure	NULL
and	NULL
function	NULL
comes	NULL
from	NULL
studies	NULL
of	NULL
small	NULL
DNA	NULL
constructs	NULL
containing	NULL
the	NULL
LTR	NULL
linked	NULL
to	NULL
reporter	NULL
genes	NULL
and	NULL
tested	NULL
in	NULL
HeLa	NULL
cells	NULL
or	NULL
in	NULL
human	NULL
T-cell	NULL
lines	NULL
(	NULL
2	NULL
,	NULL
5	NULL
,	NULL
15	NULL
,	NULL
28	NULL
,	NULL
32	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Although	NULL
this	NULL
approach	NULL
has	NULL
helped	NULL
to	NULL
elucidate	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
the	NULL
HIV	NULL
LTR	NULL
is	NULL
activated	NULL
,	NULL
the	NULL
interaction	NULL
of	NULL
virus	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

t	NULL
Present	NULL
address	NULL
:	NULL
Center	NULL
for	NULL
Advanced	NULL
Biotechnology	NULL
and	NULL
Medicine	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
08854	NULL
.	NULL

4350	NULL
encoded	NULL
and	NULL
cellular	NULL
proteins	NULL
with	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
during	NULL
a	NULL
productive	NULL
infection	NULL
can	NULL
not	NULL
be	NULL
evaluated	NULL
in	NULL
such	NULL
systems	NULL
.	NULL

We	NULL
(	NULL
23	NULL
)	NULL
and	NULL
others	NULL
(	NULL
14	NULL
,	NULL
24	NULL
)	NULL
have	NULL
elected	NULL
to	NULL
evaluate	NULL
LTR	NULL
function	NULL
in	NULL
the	NULL
context	NULL
of	NULL
HIV	NULL
replication	NULL
and	NULL
have	NULL
previously	NULL
reported	NULL
that	NULL
some	NULL
of	NULL
the	NULL
cis-acting	NULL
elements	NULL
may	NULL
be	NULL
dispensable	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
cell	NULL
type	NULL
infected	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
deletion	NULL
of	NULL
both	NULL
NF-kB	NULL
elements	NULL
only	NULL
modestly	NULL
affects	NULL
HIV	NULL
replication	NULL
in	NULL
PBLs	NULL
or	NULL
in	NULL
CEM	NULL
and	NULL
MT4	NULL
cells	NULL
(	NULL
23	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutation	NULL
of	NULL
Spl	NULL
motifs	NULL
can	NULL
drastically	NULL
reduce	NULL
replicative	NULL
capacity	NULL
in	NULL
some	NULL
human	NULL
T-cell	NULL
cultures	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
the	NULL
deletion	NULL
of	NULL
all	NULL
three	NULL
Spl	NULL
elements	NULL
either	NULL
eliminated	NULL
or	NULL
greatly	NULL
reduced	NULL
the	NULL
capacity	NULL
of	NULL
HIV	NULL
to	NULL
infect	NULL
CEM	NULL
cells	NULL
(	NULL
two	NULL
successes	NULL
in	NULL
five	NULL
independent	NULL
exper-iments	NULL
)	NULL
;	NULL
replication	NULL
of	NULL
this	NULL
mutant	NULL
in	NULL
PBLs	NULL
and	NULL
MT4	NULL
cells	NULL
was	NULL
only	NULL
slightly	NULL
reduced	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
simultaneous	NULL
elimination	NULL
of	NULL
the	NULL
two	NULL
NF-kB	NULL
and	NULL
all	NULL
three	NULL
Spl	NULL
elements	NULL
resulted	NULL
in	NULL
a	NULL
provirus	NULL
exhibiting	NULL
no	NULL
detectable	NULL
biological	NULL
activity	NULL
(	NULL
23	NULL
)	NULL
;	NULL
in	NULL
this	NULL
report	NULL
,	NULL
we	NULL
refer	NULL
to	NULL
this	NULL
irreversibly	NULL
replication-incompetent	NULL
proviral	NULL
DNA	NULL
as	NULL
pNL-ZERO	NULL
.	NULL

To	NULL
understand	NULL
more	NULL
fully	NULL
the	NULL
contribution	NULL
of	NULL
individual	NULL
LTR	NULL
components	NULL
to	NULL
the	NULL
replicative	NULL
process	NULL
and	NULL
to	NULL
the	NULL
complex	NULL
interactions	NULL
of	NULL
cellular	NULL
and	NULL
viral	NULL
proteins	NULL
with	NULL
their	NULL
LTR	NULL
targets	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
biological	NULL
activity	NULL
of	NULL
pNL-ZERO	NULL
into	NULL
which	NULL
different	NULL
combinations	NULL
of	NULL
NF-kB	NULL
and	NULL
Spl	NULL
cis-acting	NULL
elements	NULL
were	NULL
added	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
a	NULL
hierarchy	NULL
of	NULL
cellular	NULL
permissivity	NULL
to	NULL
virus	NULL
infection	NULL
which	NULL
very	NULL
likely	NULL
reflects	NULL
the	NULL
relative	NULL
abundance	NULL
of	NULL
transcriptional	NULL
regulatory	NULL
factors	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
specific	NULL
HIV	NULL
LTR	NULL
motifs	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Construction	NULL
of	NULL
proviral	NULL
DNAs	NULL
containing	NULL
LTR	NULL
mutations	NULL
and	NULL
generation	NULL
of	NULL
virus	NULL
stocks	NULL
.	NULL

pNL-ZERO	NULL
is	NULL
a	NULL
replication-incompetent	NULL
derivative	NULL
of	NULL
the	NULL
infectious	NULL
circularly	NULL
permuted	NULL
proviral	NULL
clone	NULL
pILIC	NULL
(	NULL
23	NULL
)	NULL
;	NULL
pNL-ZERO	NULL
lacks	NULL
the	NULL
two	NULL
NF-kB	NULL
Vor	NULL
.	NULL

65	NULL
,	NULL
1991	NULL
and	NULL
three	NULL
Spl	NULL
sites	NULL
and	NULL
was	NULL
previously	NULL
designated	NULL
pTA	NULL
.	NULL

pNL-ZERO	NULL
DNA	NULL
was	NULL
digested	NULL
with	NULL
BamHI	NULL
and	NULL
SphI	NULL
to	NULL
generate	NULL
a	NULL
2.1-kb	NULL
fragment	NULL
containing	NULL
the	NULL
LTR	NULL
.	NULL

This	NULL
fragment	NULL
was	NULL
subcloned	NULL
into	NULL
M13	NULL
and	NULL
subsequently	NULL
used	NULL
to	NULL
produce	NULL
the	NULL
reconstructed	NULL
LTRs	NULL
,	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
by	NULL
oligonucleotide-directed	NULL
mutagenesis	NULL
(	NULL
47	NULL
)	NULL
as	NULL
modified	NULL
by	NULL
Kunkel	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Full-length	NULL
circularly	NULL
permuted	NULL
proviral	NULL
DNAs	NULL
were	NULL
reconstituted	NULL
by	NULL
ligating	NULL
the	NULL
LTR-containing	NULL
1.7-kb	NULL
Xhol-SphI	NULL
fragment	NULL
from	NULL
M13	NULL
recombinants	NULL
to	NULL
a	NULL
similarly	NULL
digested	NULL
7.4-kb	NULL
cleavage	NULL
product	NULL
of	NULL
pNL-ZERO	NULL
.	NULL

Following	NULL
the	NULL
verification	NULL
of	NULL
the	NULL
mutations	NULL
prepared	NULL
in	NULL
vitro	NULL
by	NULL
nucleotide	NULL
sequence	NULL
analysis	NULL
(	NULL
34	NULL
)	NULL
,	NULL
the	NULL
replicative	NULL
capacities	NULL
of	NULL
the	NULL
different	NULL
LTR	NULL
mutants	NULL
were	NULL
evaluated	NULL
by	NULL
transfecting	NULL
a	NULL
derivative	NULL
of	NULL
A3.01	NULL
(	NULL
9	NULL
)	NULL
CEM	NULL
cells	NULL
,	NULL
designated	NULL
12D7	NULL
(	NULL
gener-ously	NULL
provided	NULL
by	NULL
Guido	NULL
Poli	NULL
,	NULL
Laboratory	NULL
of	NULL
Immunoregu-lation	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Diseases	NULL
)	NULL
with	NULL
3	NULL
ug	NULL
of	NULL
DNA	NULL
(	NULL
per	NULL
6	NULL
x	NULL
10°	NULL
cells	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
DEAE-dextran	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Forty-eight	NULL
hours	NULL
later	NULL
,	NULL
the	NULL
transfected	NULL
cells	NULL
were	NULL
cocultivated	NULL
with	NULL
2	NULL
x	NULL
10°	NULL
MT4	NULL
(	NULL
25	NULL
)	NULL
cells	NULL
and	NULL
monitored	NULL
for	NULL
virus	NULL
production	NULL
by	NULL
a	NULL
*P-reverse	NULL
transcriptase	NULL
(	NULL
RT	NULL
)	NULL
assay	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Virus	NULL
stocks	NULL
were	NULL
prepared	NULL
from	NULL
the	NULL
supernatants	NULL
of	NULL
transfection-cocultures	NULL
when	NULL
RT	NULL
levels	NULL
exceeded	NULL
3,500	NULL
*P	NULL
cpm/pl	NULL
.	NULL

Infections	NULL
.	NULL

PBLs	NULL
,	NULL
the	NULL
A3.01	NULL
(	NULL
9	NULL
)	NULL
clonal	NULL
derivative	NULL
of	NULL
CEM	NULL
cells	NULL
,	NULL
MT4	NULL
,	NULL
H9	NULL
(	NULL
31	NULL
)	NULL
,	NULL
and	NULL
JE6.1	NULL
(	NULL
45	NULL
)	NULL
,	NULL
a	NULL
clonal	NULL
line	NULL
of	NULL
Jurkat	NULL
cells	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
cells	NULL
of	NULL
each	NULL
type	NULL
)	NULL
,	NULL
were	NULL
infected	NULL
with	NULL
equivalent	NULL
amounts	NULL
of	NULL
virus	NULL
(	NULL
300,000	NULL
cpm	NULL
of	NULL
*°P-RT	NULL
activi-ty	NULL
)	NULL
.	NULL

Prior	NULL
to	NULL
infection	NULL
,	NULL
PBLs	NULL
were	NULL
stimulated	NULL
with	NULL
phytohe-magglutinin	NULL
(	NULL
0.25	NULL
pg/ml	NULL
)	NULL
for	NULL
3	NULL
days	NULL
;	NULL
upon	NULL
infection	NULL
,	NULL
the	NULL
PBLs	NULL
were	NULL
maintained	NULL
in	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
interleukin	NULL
2	NULL
.	NULL

Infected	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
T25	NULL
Teflon	NULL
flasks	NULL
(	NULL
Costar	NULL
)	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
10	NULL
ml	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
and	NULL
progeny	NULL
virion	NULL
production	NULL
was	NULL
detected	NULL
by	NULL
RT	NULL
activity	NULL
.	NULL

PCR	NULL
analysis	NULL
of	NULL
genomic	NULL
RNA	NULL
.	NULL

Aliquots	NULL
(	NULL
100	NULL
pl	NULL
)	NULL
of	NULL
culture	NULL
supernatants	NULL
from	NULL
selected	NULL
infections	NULL
were	NULL
digested	NULL
with	NULL
©	NULL
RNase-free	NULL
DNase	NULL
(	NULL
0.05	NULL
U	NULL
;	NULL
Promega	NULL
Biotec	NULL
)	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
10	NULL
min	NULL
at	NULL
68°C	NULL
to	NULL
inactivate	NULL
the	NULL
DNase	NULL
.	NULL

First-strand	NULL
cDNA	NULL
synthesis	NULL
from	NULL
viral	NULL
RNA	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
Morgan	NULL
et	NULL
al	NULL
.	NULL

(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
cDNAs	NULL
were	NULL
then	NULL
amplified	NULL
in	NULL
a	NULL
Perkin-Elmer/Cetus	NULL
DNA	NULL
Thermal	NULL
Cycler	NULL
with	NULL
the	NULL
following	NULL
primers	NULL
:	NULL
(	NULL
i	NULL
)	NULL
a	NULL
plus-sense	NULL
oligonucleotide	NULL
spanning	NULL
positions	NULL
9073	NULL
to	NULL
9092	NULL
(	NULL
HIV	NULL
gr	NULL
,	NULL
,	NULL
coordinates	NULL
[	NULL
27	NULL
]	NULL
)	NULL
with	NULL
9	NULL
nucleotides	NULL
at	NULL
its	NULL
5	NULL
'	NULL
end	NULL
bearing	NULL
an	NULL
EcoRI	NULL
site	NULL
(	NULL
5-ATCGAATTCTGGAAGGGCTAATTCACTCC-3	NULL
;	NULL
gift	NULL
from	NULL
Jonathan	NULL
Silver	NULL
)	NULL
,	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
a	NULL
minus-sense	NULL
oligonucleotide	NULL
spanning	NULL
positions	NULL
9504	NULL
to	NULL
9521	NULL
with	NULL
12	NULL
nucleotides	NULL
at	NULL
its	NULL
5	NULL
end	NULL
bearing	NULL
both	NULL
a	NULL
PstI	NULL
and	NULL
an	NULL
Rsal	NULL
site	NULL
(	NULL
S	NULL
!	NULL

-AACTG	NULL
CAGGTACCAGGCAAAAAGCAGCTGC-3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
amplification	NULL
protocol	NULL
consisted	NULL
of	NULL
denaturation	NULL
at	NULL
94°C	NULL
for	NULL
30	NULL
s	NULL
,	NULL
annealing	NULL
at	NULL
60°C	NULL
for	NULL
30	NULL
s	NULL
,	NULL
and	NULL
extension	NULL
at	NULL
72°C	NULL
for	NULL
2	NULL
min	NULL
.	NULL

Digestion	NULL
of	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
product	NULL
with	NULL
EcoRI	NULL
and	NULL
Psil	NULL
,	NULL
ligation	NULL
into	NULL
pIBI30	NULL
(	NULL
International	NULL
Biotechnologies	NULL
,	NULL
Inc.	NULL
)	NULL
,	NULL
transformation	NULL
of	NULL
Escherichia	NULL
coli	NULL
DHS-	NULL
«	NULL
MCR	NULL
(	NULL
Bethesda	NULL
Research	NULL
Laboratories	NULL
)	NULL
,	NULL
and	NULL
selection	NULL
of	NULL
recombinants	NULL
by	NULL
colony	NULL
hybridization	NULL
by	NULL
using	NULL
a	NULL
5'-end-labeled	NULL
oligonucleotide	NULL
probe	NULL
spanning	NULL
positions	NULL
143	NULL
to	NULL
182	NULL
of	NULL
the	NULL
(	NULL
1	NULL
,	NULL
27	NULL
)	NULL
LTR	NULL
were	NULL
all	NULL
done	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Hybridization-positive	NULL
recombinants	NULL
were	NULL
sequenced	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Sanger	NULL
et	NULL
al	NULL
.	NULL

(	NULL
34	NULL
)	NULL
.	NULL

RESULTS	NULL
We	NULL
previously	NULL
described	NULL
the	NULL
construction	NULL
of	NULL
a	NULL
circularly	NULL
permuted	NULL
infectious	NULL
molecular	NULL
clone	NULL
of	NULL
HIV	NULL
containing	NULL
a	NULL
single	NULL
LTR	NULL
which	NULL
was	NULL
used	NULL
to	NULL
investigate	NULL
the	NULL
role	NULL
(	NULL
s	NULL
)	NULL
of	NULL
RECONSTRUCTED	NULL
HIV	NULL
LTRs	NULL
4351	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Spl	NULL
elements	NULL
during	NULL
virus	NULL
replication	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Viruses	NULL
in	NULL
which	NULL
the	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
were	NULL
deleted	NULL
replicated	NULL
efficiently	NULL
in	NULL
phytohemagglutinin-stimulated	NULL
human	NULL
PBLs	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
MT4	NULL
and	NULL
CEM	NULL
cells	NULL
.	NULL

HIV	NULL
preparations	NULL
containing	NULL
one	NULL
or	NULL
two	NULL
mutated	NULL
Spl	NULL
binding	NULL
sites	NULL
were	NULL
also	NULL
replication	NULL
competent	NULL
but	NULL
exhibited	NULL
variable	NULL
growth	NULL
kinetics	NULL
depending	NULL
on	NULL
the	NULL
cell	NULL
type	NULL
infected	NULL
.	NULL

Deletion	NULL
of	NULL
all	NULL
three	NULL
Spl	NULL
sites	NULL
resulted	NULL
in	NULL
virus	NULL
which	NULL
replicated	NULL
efficiently	NULL
in	NULL
MT4	NULL
cells	NULL
and	NULL
in	NULL
PBLs	NULL
but	NULL
inconsistently	NULL
and	NULL
with	NULL
delayed	NULL
kinetics	NULL
in	NULL
CEM	NULL
T	NULL
cells	NULL
unless	NULL
they	NULL
were	NULL
exposed	NULL
to	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
30	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
deletion	NULL
of	NULL
68	NULL
bp	NULL
of	NULL
U3	NULL
sequences	NULL
encompassing	NULL
the	NULL
two	NULL
NF-kB	NULL
and	NULL
the	NULL
three	NULL
Spl	NULL
sites	NULL
generated	NULL
an	NULL
HIV	NULL
provirus	NULL
which	NULL
failed	NULL
to	NULL
replicate	NULL
following	NULL
transfection-cocultivation	NULL
.	NULL

This	NULL
replication-defective	NULL
HIV	NULL
provirus	NULL
,	NULL
designated	NULL
pNL-ZERO	NULL
,	NULL
was	NULL
used	NULL
in	NULL
a	NULL
series	NULL
of	NULL
experiments	NULL
as	NULL
a	NULL
basal-level	NULL
proviral	NULL
DNA	NULL
target	NULL
to	NULL
which	NULL
NF-kB	NULL
or	NULL
Spl	NULL
sites	NULL
were	NULL
added	NULL
either	NULL
individually	NULL
or	NULL
in	NULL
combination	NULL
.	NULL

Generation	NULL
of	NULL
mutant	NULL
LTR	NULL
HIV-1	NULL
stocks	NULL
by	NULL
transfection-cocultivation	NULL
.	NULL

Circularly	NULL
permuted	NULL
HIV	NULL
proviruses	NULL
containing	NULL
a	NULL
single	NULL
wild-type	NULL
or	NULL
reconstructed	NULL
LTR	NULL
were	NULL
released	NULL
from	NULL
plasmid	NULL
vectors	NULL
following	NULL
digestion	NULL
with	NULL
BamHI	NULL
and	NULL
ligated	NULL
to	NULL
regenerate	NULL
``	NULL
``	NULL
conventional	NULL
``	NULL
full-length	NULL
proviral	NULL
DNAs	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
containing	NULL
at	NULL
least	NULL
two	NULL
LTRs	NULL
)	NULL
.	NULL

A	NULL
cloned	NULL
derivative	NULL
of	NULL
the	NULL
CD4*	NULL
T-cell	NULL
line	NULL
A3.01	NULL
,	NULL
designated	NULL
12D7	NULL
,	NULL
was	NULL
then	NULL
transfected	NULL
with	NULL
the	NULL
ligated	NULL
proviral	NULL
DNAs	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Forty-eight	NULL
hours	NULL
following	NULL
trans-fection	NULL
,	NULL
the	NULL
12D7	NULL
cells	NULL
were	NULL
cocultivated	NULL
with	NULL
MT4	NULL
cells	NULL
and	NULL
progeny	NULL
virus	NULL
production	NULL
was	NULL
then	NULL
monitored	NULL
by	NULL
RT	NULL
assay	NULL
over	NULL
a	NULL
51-day	NULL
period	NULL
.	NULL

Supernatants	NULL
were	NULL
collected	NULL
at	NULL
the	NULL
peak	NULL
of	NULL
RT	NULL
activity	NULL
and	NULL
served	NULL
as	NULL
virus	NULL
stocks	NULL
for	NULL
subsequent	NULL
infectivity	NULL
studies	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
transfection-cocultivation	NULL
with	NULL
wild-type	NULL
HIV	NULL
proviral	NULL
DNA	NULL
resulted	NULL
in	NULL
rapid	NULL
virus	NULL
production	NULL
(	NULL
first	NULL
detected	NULL
4	NULL
to	NULL
5	NULL
days	NULL
later	NULL
)	NULL
,	NULL
whereas	NULL
pNL-ZERO	NULL
failed	NULL
to	NULL
replicate	NULL
.	NULL

As	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
virus	NULL
production	NULL
was	NULL
observed	NULL
following	NULL
transfection-cocultivation	NULL
of	NULL
proviral	NULL
DNAs	NULL
containing	NULL
one	NULL
or	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
elements	NULL
,	NULL
although	NULL
replication	NULL
of	NULL
the	NULL
former	NULL
(	NULL
pNL-1kB	NULL
)	NULL
was	NULL
markedly	NULL
delayed	NULL
(	NULL
first	NULL
detected	NULL
on	NULL
day	NULL
27	NULL
)	NULL
.	NULL

Cloned	NULL
HIV	NULL
proviruses	NULL
containing	NULL
two	NULL
or	NULL
three	NULL
Sp1	NULL
sites	NULL
and	NULL
pNL-3Sp1	NULL
)	NULL
or	NULL
a	NULL
single	NULL
pair	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Spl	NULL
sites	NULL
separated	NULL
by	NULL
a	NULL
mutated	NULL
intervening	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
(	NULL
pNL-	NULL
«	NULL
B/Sp1-R	NULL
)	NULL
all	NULL
replicated	NULL
following	NULL
transfection-cocultivation	NULL
but	NULL
with	NULL
kinetics	NULL
somewhat	NULL
slower	NULL
than	NULL
that	NULL
of	NULL
wild	NULL
type	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
pNL-	NULL
«	NULL
B/	NULL
Sp1-J	NULL
provirus	NULL
containing	NULL
juxtaposed	NULL
NF-kB	NULL
and	NULL
Spl	NULL
single	NULL
elements	NULL
replicated	NULL
nearly	NULL
as	NULL
efficiently	NULL
as	NULL
wild-type	NULL
HIV	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Of	NULL
the	NULL
mutated	NULL
HIV	NULL
LTRs	NULL
evaluated	NULL
by	NULL
transfection-cocultivation	NULL
,	NULL
only	NULL
the	NULL
pNL-1Sp1l	NULL
proviral	NULL
con-struction	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
single	NULL
Spl	NULL
element	NULL
Sp1	NULL
(	NULL
I	NULL
)	NULL
,	NULL
failed	NULL
to	NULL
replicate	NULL
in	NULL
three	NULL
independent	NULL
experiments	NULL
lasting	NULL
51	NULL
days	NULL
,	NULL
2.5	NULL
months	NULL
,	NULL
and	NULL
4	NULL
months	NULL
,	NULL
respectively	NULL
.	NULL

Infection	NULL
of	NULL
PBLs	NULL
and	NULL
human	NULL
T-cell	NULL
lines	NULL
with	NULL
HIV-1	NULL
derivatives	NULL
containing	NULL
NF-xB	NULL
or	NULL
Spl	NULL
motifs	NULL
in	NULL
their	NULL
reconstructed	NULL
LTRs	NULL
.	NULL

Although	NULL
the	NULL
transfection-cocultivation	NULL
experiments	NULL
described	NULL
above	NULL
indicated	NULL
which	NULL
of	NULL
the	NULL
NF-kB/	NULL
Spl	NULL
insertions	NULL
into	NULL
the	NULL
pNL-ZERO	NULL
LTR	NULL
restored	NULL
replicative	NULL
capacity	NULL
,	NULL
how	NULL
these	NULL
elements	NULL
influenced	NULL
virus	NULL
infectivity	NULL
required	NULL
additional	NULL
investigation	NULL
.	NULL

Infections	NULL
were	NULL
therefore	NULL
performed	NULL
employing	NULL
virus	NULL
stocks	NULL
generated	NULL
from	NULL
the	NULL
transfection-cocultures	NULL
referred	NULL
to	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
various	NULL
T-cell	NULL
lines	NULL
were	NULL
infected	NULL
with	NULL
equivalent	NULL
amounts	NULL
of	NULL
wild-type	NULL
or	NULL
LTR	NULL
mutant	NULL
virus	NULL
(	NULL
3	NULL
x	NULL
10°	NULL
*°P-RT	NULL
cpm	NULL
,	NULL
approximately	NULL
equal	NULL
to	NULL
a	NULL
multiplicity	NULL
of	NULL
infection	NULL
of	NULL
0.001	NULL
for	NULL
wild-type	NULL
virus	NULL
)	NULL
,	NULL
and	NULL
subsequent	NULL
progeny	NULL
virus	NULL
production	NULL
was	NULL
monitored	NULL
by	NULL
RT	NULL
activity	NULL
.	NULL

4352	NULL
ROSS	NULL
ET	NULL
AL	NULL
.	NULL

J.	NULL
Viror	NULL
.	NULL

N	NULL
F-kB	NULL
1	NULL
TATA	NULL
-341	NULL
-186	NULL
-106	NULL
-56	NULL
+42	NULL
p	NULL
//	NULL
/	NULL
//	NULL
////	NULL
,	NULL
/	NULL
PLASMID	NULL
virus	NULL
PRODUCED	NULL
NF-kB	NULL
(	NULL
11	NULL
)	NULL
NF-kB	NULL
(	NULL
1	NULL
)	NULL
_	NULL
Spi¢il	NULL
)	NULL
Sp1	NULL
(	NULL
!	NULL
)	NULL

pNL-WT	NULL
TACAAGGGACTTTCCGCTGGGGACTTICCAGGGAGGCGTGGCCTGGGCGGGACTGGGGAGTGGCGAGCCCTC	NULL
+	NULL
pNL-ZERO	NULL
TAC	NULL
crc	NULL
A	NULL
pNL-1kB	NULL
TAC	NULL
GCTGGGGACTTTCCAG	NULL
AGCCcre	NULL
pNL-2kB	NULL
TACAAGGGACTTTCCGCTGGGGACTTTCCAG	NULL
CIC	NULL
TAC	NULL
TGGGGAGTGGCGAGCCCTC	NULL
B-	NULL
pML-25p1	NULL
Tac	NULL
pNL-3Sp1	NULL
Tac	NULL
pNL-kB/Sp1-J	NULL
TAC	NULL
C	NULL
pNL~kB/Sp1-R	NULL
GCTGGGGACTTTCCAGGGAGGCGTGGCC	NULL
TACAAGGGACTTTCCGCTGCTCACTTTCCAGGGAGGCGTGGCC	NULL
CTGGGCGGGACTGGGGAGTGGCGAGCCCTC	NULL
GAGGCGTGGCCTGGGCGGGACTGGGGAGTGGCGAGCCCTC	NULL
AGCCCrc	NULL
+	NULL
AGCCCTC	NULL
+	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Structure	NULL
of	NULL
reconstructed	NULL
HIV	NULL
LTRs	NULL
associated	NULL
with	NULL
full-length	NULL
proviral	NULL
DNAs	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
several	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
within	NULL
the	NULL
HIV-1	NULL
LTR	NULL
are	NULL
indicated	NULL
diagrammatically	NULL
at	NULL
the	NULL
top	NULL
.	NULL

The	NULL
nucleotide	NULL
sequences	NULL
of	NULL
a	NULL
72-bp	NULL
region	NULL
encompassing	NULL
the	NULL
NF-kB	NULL
and	NULL
Spl	NULL
motifs	NULL
of	NULL
the	NULL
wild-type	NULL
LTR	NULL
(	NULL
pNL-WT	NULL
)	NULL
as	NULL
well	NULL
as	NULL
eight	NULL
reconstructed	NULL
LTRs	NULL
are	NULL
shown	NULL
below	NULL
.	NULL

The	NULL
nucleotide	NULL
substitution	NULL
in	NULL
pNL-	NULL
«	NULL
B/Spl-R	NULL
,	NULL
previously	NULL
reported	NULL
(	NULL
28	NULL
)	NULL
to	NULL
inactivate	NULL
the	NULL
NF-kB	NULL
binding	NULL
site	NULL
,	NULL
is	NULL
underlined	NULL
.	NULL

Virus	NULL
production	NULL
following	NULL
transfection-	NULL
cocultivation	NULL
is	NULL
indicated	NULL
in	NULL
the	NULL
column	NULL
at	NULL
the	NULL
right	NULL
.	NULL

In	NULL
the	NULL
first	NULL
group	NULL
of	NULL
experiments	NULL
,	NULL
PBLs	NULL
and	NULL
different	NULL
T-cell	NULL
lines	NULL
(	NULL
MT4	NULL
,	NULL
CEM	NULL
[	NULL
A3.01	NULL
clone	NULL
]	NULL
,	NULL
H9	NULL
,	NULL
and	NULL
Jurkat	NULL
[	NULL
clone	NULL
JE6.1	NULL
]	NULL
)	NULL
were	NULL
infected	NULL
with	NULL
mutant	NULL
HIV	NULL
preparations	NULL
containing	NULL
one	NULL
or	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
elements	NULL
(	NULL
and	NULL
no	NULL
Spl	NULL
motifs	NULL
)	NULL
.	NULL

Three	NULL
different	NULL
replicative	NULL
phenotypes	NULL
were	NULL
observed	NULL
.	NULL

The	NULL
first	NULL
,	NULL
seen	NULL
with	NULL
PBLs	NULL
or	NULL
MT4	NULL
cells	NULL
,	NULL
was	NULL
characterized	NULL
by	NULL
delayed	NULL
replication	NULL
as	NULL
the	NULL
number	NULL
of	NULL
NF-KB	NULL
sites	NULL
was	NULL
reduced	NULL
from	NULL
two	NULL
to	NULL
one	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

In	NULL
H9	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
and	NULL
A3.01	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
cells	NULL
,	NULL
however	NULL
,	NULL
HIV	NULL
with	NULL
the	NULL
single	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
I	NULL
)	NULL
element	NULL
failed	NULL
to	NULL
replicate	NULL
;	NULL
virus	NULL
containing	NULL
two	NULL
NF-KB	NULL
sites	NULL
in	NULL
its	NULL
reconstructed	NULL
LTR	NULL
replicated	NULL
slowly	NULL
compared	NULL
with	NULL
wild-type	NULL
HIV	NULL
,	NULL
generating	NULL
virus	NULL
progeny	NULL
2.5	NULL
to	NULL
4	NULL
weeks	NULL
postinfection	NULL
.	NULL

Notably	NULL
,	NULL
infection	NULL
of	NULL
A3.01	NULL
cells	NULL
with	NULL
HIV	NULL
containing	NULL
only	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
elements	NULL
resulted	NULL
in	NULL
virus	NULL
production	NULL
in	NULL
only	NULL
one	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
(	NULL
the	NULL
one	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
monitored	NULL
for	NULL
periods	NULL
of	NULL
up	NULL
to	NULL
42	NULL
days	NULL
.	NULL

The	NULL
third	NULL
replicative	NULL
phenotype	NULL
was	NULL
observed	NULL
in	NULL
Jurkat	NULL
cells	NULL
and	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2D	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
virus	NULL
with	NULL
LTRs	NULL
containing	NULL
one	NULL
or	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
elements	NULL
failed	NULL
to	NULL
replicate	NULL
during	NULL
nearly	NULL
4	NULL
weeks	NULL
of	NULL
observation	NULL
.	NULL

A	NULL
similar	NULL
approach	NULL
was	NULL
followed	NULL
to	NULL
monitor	NULL
the	NULL
role	NULL
of	NULL
Spl	NULL
motifs	NULL
on	NULL
virus	NULL
infectivity	NULL
.	NULL

Since	NULL
no	NULL
virus	NULL
was	NULL
generated	NULL
following	NULL
transfection-cocultivation	NULL
of	NULL
pNL-1Sp1	NULL
,	NULL
the	NULL
infectivity	NULL
studies	NULL
were	NULL
limited	NULL
to	NULL
virus	NULL
stocks	NULL
containing	NULL
two	NULL
[	NULL
Sp1l	NULL
(	NULL
I	NULL
)	NULL
plus	NULL
Sp1l	NULL
(	NULL
ID	NULL
)	NULL
or	NULL
three	NULL
[	NULL
Sp1	NULL
(	NULL
D	NULL
)	NULL
plus	NULL
Sp1	NULL
(	NULL
II	NULL
)	NULL
plus	NULL
Sp1	NULL
(	NULL
IID	NULL
)	NULL
]	NULL
Spl	NULL
motifs	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

In	NULL
all	NULL
cell	NULL
types	NULL
tested	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
second	NULL
Spl	NULL
element	NULL
restored	NULL
infectivity	NULL
.	NULL

In	NULL
some	NULL
cells	NULL
,	NULL
HIVs	NULL
with	NULL
reconstructed	NULL
LTRs	NULL
containing	NULL
two	NULL
or	NULL
three	NULL
Spl	NULL
binding	NULL
sites	NULL
had	NULL
similar	NULL
replication	NULL
kinetics	NULL
(	NULL
PBLs	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
,	NULL
while	NULL
in	NULL
others	NULL
,	NULL
virus	NULL
harboring	NULL
only	NULL
two	NULL
Spl	NULL
elements	NULL
(	NULL
H9	NULL
cells	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
reproducibly	NULL
exhibited	NULL
retarded	NULL
growth	NULL
properties	NULL
.	NULL

Infectivity	NULL
of	NULL
HIV	NULL
preparations	NULL
with	NULL
reconstructed	NULL
LTRs	NULL
containing	NULL
combinations	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Spl	NULL
elements	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
3	NULL
,	NULL
duplications	NULL
of	NULL
either	NULL
the	NULL
NF-KB	NULL
or	NULL
Spl	NULL
element	NULL
frequently	NULL
resulted	NULL
in	NULL
enhanced	NULL
HIV	NULL
replication	NULL
.	NULL

Given	NULL
the	NULL
proximity	NULL
of	NULL
the	NULL
NF-kB	NULL
and	NULL
Spl	NULL
motifs	NULL
in	NULL
the	NULL
wild-type	NULL
LTR	NULL
configuration	NULL
,	NULL
we	NULL
wondered	NULL
whether	NULL
the	NULL
observed	NULL
augmented	NULL
replicative	NULL
capacity	NULL
was	NULL
limited	NULL
to	NULL
combinations	NULL
of	NULL
the	NULL
same	NULL
element	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
possibility	NULL
that	NULL
NF-	NULL
«	NULL
xB	NULL
and	NULL
Spl	NULL
elements	NULL
might	NULL
function	NULL
in	NULL
a	NULL
combinatorial	NULL
fashion	NULL
,	NULL
we	NULL
generated	NULL
a	NULL
provirus	NULL
containing	NULL
LTRs	NULL
with	NULL
single	NULL
copies	NULL
of	NULL
both	NULL
motifs	NULL
.	NULL

In	NULL
the	NULL
five	NULL
human	NULL
T-cell	NULL
systems	NULL
evaluated	NULL
,	NULL
this	NULL
virus	NULL
(	NULL
HIV	NULL
y	NULL
;	NULL
replicated	NULL
as	NULL
rapidly	NULL
or	NULL
more	NULL
rapidly	NULL
than	NULL
HIV	NULL
preparations	NULL
with	NULL
LTRs	NULL
harboring	NULL
duplications	NULL
or	NULL
triplications	NULL
of	NULL
the	NULL
NF-kB	NULL
or	NULL
Spl	NULL
elements	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
phenomenon	NULL
was	NULL
particularly	NULL
striking	NULL
in	NULL
Jurkat	NULL
cells	NULL
in	NULL
which	NULL
HIV	NULL
with	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
elements	NULL
failed	NULL
to	NULL
replicate	NULL
during	NULL
a	NULL
25-day	NULL
observation	NULL
period	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
NL-	NULL
«	NULL
B/Sp1-J	NULL
virus	NULL
replicated	NULL
with	NULL
kinetics	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
wild-type	NULL
HIV	NULL
in	NULL
most	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
tested	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

We	NULL
wondered	NULL
whether	NULL
the	NULL
efficient	NULL
viral	NULL
replication	NULL
directed	NULL
by	NULL
an	NULL
LTR	NULL
containing	NULL
a	NULL
pair	NULL
of	NULL
NF-kB	NULL
and	NULL
Spl	NULL
elements	NULL
reflected	NULL
their	NULL
juxtaposition	NULL
or	NULL
simply	NULL
their	NULL
presence	NULL
in	NULL
the	NULL
reconstructed	NULL
LTR	NULL
.	NULL

Consequently	NULL
,	NULL
a	NULL
different	NULL
LTR	NULL
containing	NULL
the	NULL
single	NULL
functional	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
II	NULL
)	NULL
and	NULL
Sp1	NULL
(	NULL
III	NULL
)	NULL
elements	NULL
spatially	NULL
separated	NULL
from	NULL
one	NULL
another	NULL
by	NULL
a	NULL
muta-genized	NULL
(	NULL
28	NULL
)	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
I	NULL
)	NULL
motif	NULL
(	NULL
see	NULL
the	NULL
NL-kB/Sp1l-R	NULL
provirus	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
was	NULL
examined	NULL
for	NULL
its	NULL
ability	NULL
to	NULL
support	NULL
a	NULL
productive	NULL
virus	NULL
infection	NULL
.	NULL

In	NULL
H9	NULL
cells	NULL
,	NULL
the	NULL
replicative	NULL
capacity	NULL
of	NULL
this	NULL
virus	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
virus	NULL
containing	NULL
the	NULL
juxtaposed	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
I	NULL
)	NULL
and	NULL
Sp1	NULL
(	NULL
III	NULL
)	NULL
binding	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
an	NULL
11-bp	NULL
separation	NULL
of	NULL
functional	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Sp1	NULL
sites	NULL
did	NULL
not	NULL
appreciably	NULL
affect	NULL
infectivity	NULL
;	NULL
virions	NULL
with	NULL
this	NULL
LTR	NULL
configuration	NULL
replicated	NULL
more	NULL
rapidly	NULL
than	NULL
those	NULL
containing	NULL
only	NULL
two	NULL
NF-kB	NULL
or	NULL
two	NULL
Spl	NULL
elements	NULL
.	NULL

Replicative	NULL
capacity	NULL
of	NULL
HIV	NULL
proviral	NULL
DNA	NULL
containing	NULL
a	NULL
Vor	NULL
.	NULL

65	NULL
,	NULL
1991	NULL
PBLs	NULL
Wild	NULL
type	NULL
2	NULL
NFKB	NULL
only	NULL
&	NULL
qu	NULL
1	NULL
,	NULL
NFKB	NULL
only	NULL
3000	NULL
A	NULL
C	NULL
3	NULL
w	NULL
0	NULL
o	NULL
€	NULL
-	NULL
2000	NULL
a	NULL
o	NULL
S	NULL
y	NULL
»	NULL
iE	NULL
E	NULL
t	NULL
1000	NULL
{	NULL
<	NULL
i	NULL
ce	NULL
o	NULL
0	NULL
8000	NULL
10	NULL
20	NULL
30	NULL
40	NULL
DAYS	NULL
POST	NULL
INFECTION	NULL
R.T.	NULL
ACTIVITY	NULL
(	NULL
cpm/0.S5ul	NULL
)	NULL
Wild	NULL
type	NULL
2-NFkB	NULL
-	NULL
only	NULL
CEM	NULL
1-NFKB	NULL
only	NULL
1	NULL
Il	NULL
)	NULL
20	NULL
30	NULL
DAYS	NULL
POST	NULL
INFECTION	NULL
R.T.	NULL
ACTIVITY	NULL
(	NULL
cpm/1.65ul	NULL
)	NULL
RECONSTRUCTED	NULL
HIV	NULL
LTRs	NULL
Wild	NULL
type	NULL
\	NULL
20000	NULL
B	NULL
Hg	NULL
2-NFkB	NULL
|	NULL
only	NULL
1-NFKkB	NULL
-	NULL
only	NULL
10	NULL
20	NULL
so	NULL
DAYS	NULL
POST	NULL
INFECTION	NULL
ce	NULL
R.T.	NULL
ACTIVITY	NULL
(	NULL
cpm/0.S5ul	NULL
)	NULL
f	NULL
D	NULL
Jurkat	NULL
JE6.1	NULL
Wild	NULL
type	NULL
2-NFKB	NULL
-	NULL
only	NULL
1-NFKB	NULL
only	NULL
o	NULL
T	NULL
T	NULL
a	NULL
10	NULL
20	NULL
30	NULL
DAYS	NULL
POST	NULL
INFECTION	NULL
4353	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Infections	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
with	NULL
wild-type	NULL
HIV	NULL
or	NULL
mutant	NULL
HIV	NULL
derivatives	NULL
with	NULL
LTRs	NULL
containing	NULL
one	NULL
or	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
no	NULL
Spl	NULL
elements	NULL
.	NULL

Activated	NULL
PBLs	NULL
or	NULL
H9	NULL
,	NULL
CEM	NULL
,	NULL
or	NULL
Jurkat	NULL
cells	NULL
were	NULL
infected	NULL
with	NULL
approximately	NULL
3	NULL
x	NULL
10°	NULL
*P-RT	NULL
cpm	NULL
of	NULL
the	NULL
indicated	NULL
virus	NULL
preparations	NULL
obtained	NULL
by	NULL
transfection-cocultivation	NULL
.	NULL

Virus	NULL
production	NULL
was	NULL
monitored	NULL
by	NULL
RT	NULL
assay	NULL
.	NULL

>	NULL
§	NULL
R.T.	NULL
ACTIVITY	NULL
(	NULL
cpm/0.5ul	NULL
)	NULL
1	NULL
‘	NULL
0	NULL
20	NULL
30	NULL
DAYS	NULL
POST	NULL
INFECTION	NULL
40	NULL
R.T.	NULL
ACTIVITY	NULL
(	NULL
cpm/0.5ul	NULL
)	NULL
Wild	NULL
type	NULL
H	NULL
9	NULL
3-Sp1	NULL
only	NULL
2-Sp1	NULL
only	NULL
A\	NULL
M	NULL
1,0	NULL
2.0	NULL
30	NULL
DAYS	NULL
POST	NULL
INFECTION	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Infections	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
with	NULL
wild-type	NULL
HIV	NULL
or	NULL
mutant	NULL
HIV	NULL
derivatives	NULL
with	NULL
LTRs	NULL
containing	NULL
two	NULL
or	NULL
three	NULL
Spl	NULL
and	NULL
no	NULL
NF-	NULL
«	NULL
B	NULL
elements	NULL
.	NULL

Activated	NULL
PBLs	NULL
or	NULL
H9	NULL
cells	NULL
were	NULL
infected	NULL
with	NULL
the	NULL
indicated	NULL
virus	NULL
preparations	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Virus	NULL
production	NULL
was	NULL
monitored	NULL
by	NULL
RT	NULL
assay	NULL
.	NULL

4354	NULL
ROSS	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
7000	NULL
I	NULL
JURKAT	NULL
JE6.1	NULL
3	NULL
-	NULL
sooo	NULL
4	NULL
t	NULL
9	NULL
£	NULL
sooo	NULL
{	NULL
a	NULL
.	NULL

Wild	NULL
type	NULL
J	NULL
4000	NULL
E	NULL
only	NULL
E	NULL
3000	NULL
2	NULL
Juxtaposed	NULL
2000	NULL
-	NULL
NFKB/Sp1	NULL
E	NULL
©	NULL
_	NULL
1000	NULL
<	NULL
2-NFKB	NULL
|	NULL
only	NULL
o	NULL
10	NULL
20	NULL
30	NULL
DAYS	NULL
POST	NULL
INFECTION	NULL
J.	NULL
Viror	NULL
.	NULL

B	NULL
8000	NULL
fre	NULL
2-	NULL
$	NULL
p1	NULL
-	NULL
only	NULL
CEM	NULL
3	NULL
AMC	NULL
2	NULL
Juxtaposed	NULL
25	NULL
sooo	NULL
-	NULL
NFkB/Sp1	NULL
a	NULL
.	NULL

Wild	NULL
type	NULL
\	NULL
S	NULL
ys	NULL
E	NULL
_	NULL
40004	NULL
A	NULL
>	NULL
»	NULL
=	NULL
2-NFKB	NULL
-	NULL
only	NULL
0	NULL
<	NULL
Bi	NULL
-	NULL
2000	NULL
<	NULL
C	NULL
0	NULL
T	NULL
T	NULL
T	NULL
0	NULL
10	NULL
20	NULL
so	NULL
DAYS	NULL
POST	NULL
INFECTION	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Infections	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
with	NULL
wild-type	NULL
HIV	NULL
or	NULL
mutant	NULL
HIV	NULL
derivatives	NULL
with	NULL
LTRs	NULL
containing	NULL
pairs	NULL
of	NULL
homologous	NULL
or	NULL
heterologous	NULL
cis-acting	NULL
elements	NULL
.	NULL

Jurkat	NULL
or	NULL
CEM	NULL
cells	NULL
were	NULL
infected	NULL
with	NULL
the	NULL
indicated	NULL
virus	NULL
preparations	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Virus	NULL
production	NULL
was	NULL
monitored	NULL
by	NULL
RT	NULL
assay	NULL
.	NULL

single	NULL
enhancer-activator	NULL
element	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
5	NULL
suggest	NULL
that	NULL
paired	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Spl	NULL
elements	NULL
are	NULL
acting	NULL
in	NULL
a	NULL
combinatorial	NULL
manner	NULL
since	NULL
HIV	NULL
preparations	NULL
with	NULL
duplications	NULL
of	NULL
the	NULL
same	NULL
elements	NULL
exhibited	NULL
an	NULL
impaired	NULL
replication	NULL
phenotype	NULL
in	NULL
some	NULL
cell	NULL
lines	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
transfection-cocultivation	NULL
results	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
indicated	NULL
that	NULL
the	NULL
single	NULL
Spi	NULL
motif	NULL
Sp1	NULL
(	NULL
I	NULL
)	NULL
failed	NULL
to	NULL
restore	NULL
replication	NULL
competence	NULL
to	NULL
pNL-ZERO	NULL
,	NULL
suggesting	NULL
that	NULL
a	NULL
single	NULL
Spl	NULL
element	NULL
could	NULL
not	NULL
direct	NULL
virus	NULL
production	NULL
unless	NULL
it	NULL
was	NULL
associated	NULL
with	NULL
either	NULL
a	NULL
second	NULL
Spl	NULL
element	NULL
or	NULL
an	NULL
NF-kB	NULL
element	NULL
.	NULL

These	NULL
conclusions	NULL
all	NULL
assume	NULL
that	NULL
the	NULL
biological	NULL
activity	NULL
of	NULL
each	NULL
of	NULL
the	NULL
single	NULL
NF-kB	NULL
or	NULL
Spl	NULL
elements	NULL
can	NULL
be	NULL
predicted	NULL
from	NULL
the	NULL
data	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

However	NULL
,	NULL
since	NULL
the	NULL
sequences	NULL
of	NULL
the	NULL
different	NULL
or	NULL
Spl	NULL
motifs	NULL
in	NULL
the	NULL
HIV-1	NULL
LTR	NULL
are	NULL
not	NULL
identical	NULL
,	NULL
we	NULL
undertook	NULL
a	NULL
series	NULL
of	NULL
experiments	NULL
to	NULL
evaluate	NULL
more	NULL
critically	NULL
the	NULL
functional	NULL
contribution	NULL
of	NULL
individual	NULL
enhancer-activator	NULL
elements	NULL
in	NULL
the	NULL
reconstructed	NULL
LTRs	NULL
.	NULL

Toward	NULL
this	NULL
end	NULL
,	NULL
proviral	NULL
DNAs	NULL
containing	NULL
only	NULL
single	NULL
NF-kB	NULL
or	NULL
Spl	NULL
elements	NULL
were	NULL
8000	NULL
Wild	NULL
type	NULL
H9	NULL
a	NULL
'	NULL
RFkersp1	NULL
a	NULL
501	NULL
P	NULL
E	NULL
Separated	NULL
g	NULL
NFKB/Spi1	NULL
2+Sp	NULL
1	NULL
>	NULL
-	NULL
-	NULL
4000	NULL
{	NULL
t=	NULL
3	NULL
2-NFkB	NULL
Jo	NULL
4	NULL
2000	NULL
<	NULL
E	NULL
E3	NULL
0	NULL
T	NULL
T	NULL
T	NULL
0	NULL
10	NULL
20	NULL
30	NULL
DAYS	NULL
POST	NULL
INFECTION	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Infection	NULL
of	NULL
H9	NULL
cells	NULL
with	NULL
HIV	NULL
containing	NULL
an	NULL
LTR	NULL
with	NULL
single	NULL
separated	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Spl	NULL
elements	NULL
.	NULL

H9	NULL
cells	NULL
were	NULL
infected	NULL
with	NULL
the	NULL
indicated	NULL
virus	NULL
preparations	NULL
containing	NULL
pairs	NULL
of	NULL
homologous	NULL
or	NULL
heterologous	NULL
motifs	NULL
.	NULL

Virus	NULL
production	NULL
was	NULL
monitored	NULL
by	NULL
RT	NULL
assay	NULL
.	NULL

assayed	NULL
for	NULL
virus	NULL
production	NULL
by	NULL
transfection-cocultivation	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
and	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
data	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
a	NULL
proviral	NULL
clone	NULL
containing	NULL
only	NULL
the	NULL
Spl	NULL
element	NULL
Sp1	NULL
(	NULL
I	NULL
)	NULL
failed	NULL
to	NULL
replicate	NULL
in	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
single	NULL
Spl	NULL
motif	NULL
Sp1	NULL
(	NULL
III	NULL
)	NULL
restored	NULL
the	NULL
capacity	NULL
to	NULL
produce	NULL
virus	NULL
.	NULL

Spl	NULL
element	NULL
Sp1	NULL
(	NULL
II	NULL
)	NULL
had	NULL
an	NULL
intermediate	NULL
effect	NULL
in	NULL
these	NULL
assays	NULL
:	NULL
in	NULL
one	NULL
experiment	NULL
,	NULL
progeny	NULL
virus	NULL
was	NULL
detected	NULL
by	NULL
day	NULL
25	NULL
,	NULL
while	NULL
in	NULL
a	NULL
second	NULL
experiment	NULL
,	NULL
none	NULL
was	NULL
produced	NULL
after	NULL
77	NULL
days	NULL
.	NULL

A	NULL
similar	NULL
disparity	NULL
was	NULL
also	NULL
observed	NULL
when	NULL
the	NULL
two	NULL
NF-kB	NULL
elements	NULL
were	NULL
examined	NULL
individually	NULL
.	NULL

NF-kB	NULL
(	NULL
I	NULL
)	NULL
was	NULL
associated	NULL
with	NULL
virus	NULL
production	NULL
in	NULL
three	NULL
separate	NULL
experiments	NULL
,	NULL
whereas	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
II	NULL
)	NULL
restored	NULL
replication	NULL
competence	NULL
in	NULL
only	NULL
one	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

In	NULL
view	NULL
of	NULL
the	NULL
very	NULL
long	NULL
time	NULL
(	NULL
61	NULL
days	NULL
)	NULL
before	NULL
progeny	NULL
virions	NULL
were	NULL
detected	NULL
in	NULL
this	NULL
latter	NULL
experiment	NULL
,	NULL
the	NULL
replication	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
II	NULL
)	NULL
most	NULL
likely	NULL
reflects	NULL
a	NULL
reversion	NULL
event	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
the	NULL
LTR	NULL
sequences	NULL
of	NULL
other	NULL
late-arising	NULL
HIV	NULL
variants	NULL
(	NULL
see	NULL
next	NULL
section	NULL
)	NULL
.	NULL

It	NULL
is	NULL
our	NULL
current	NULL
belief	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
II	NULL
)	NULL
by	NULL
itself	NULL
can	NULL
not	NULL
restore	NULL
replicative	NULL
capacity	NULL
to	NULL
the	NULL
pNL-ZERO	NULL
LTR	NULL
.	NULL

Second-site	NULL
reversions	NULL
which	NULL
appear	NULL
in	NULL
reconstructed	NULL
LTRs	NULL
following	NULL
virus	NULL
infection	NULL
of	NULL
human	NULL
PBLs	NULL
or	NULL
T-cell	NULL
lines	NULL
.	NULL

We	NULL
previously	NULL
reported	NULL
that	NULL
second-site	NULL
revertants	NULL
of	NULL
replication-defective	NULL
HIV	NULL
mutants	NULL
may	NULL
emerge	NULL
during	NULL
long-term	NULL
tissue	NULL
culture	NULL
infections	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Consequently	NULL
,	NULL
the	NULL
appearance	NULL
of	NULL
progeny	NULL
virions	NULL
at	NULL
very	NULL
late	NULL
times	NULL
following	NULL
HIV	NULL
infection	NULL
in	NULL
this	NULL
study	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
a	NULL
compensatory	NULL
LTR	NULL
alteration	NULL
was	NULL
responsible	NULL
for	NULL
the	NULL
infectivity	NULL
observed	NULL
.	NULL

We	NULL
therefore	NULL
focused	NULL
attention	NULL
on	NULL
the	NULL
group	NULL
of	NULL
proviruses	NULL
containing	NULL
only	NULL
NF-	NULL
«	NULL
B	NULL
elements	NULL
in	NULL
their	NULL
reconstructed	NULL
LTRs	NULL
since	NULL
they	NULL
exhibited	NULL
a	NULL
spectrum	NULL
of	NULL
replicative	NULL
capacities	NULL
related	NULL
to	NULL
the	NULL
cell	NULL
type	NULL
infected	NULL
.	NULL

As	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
a	NULL
hierarchy	NULL
of	NULL
cellular	NULL
permissiveness	NULL
was	NULL
observed	NULL
when	NULL
HIV	NULL
harboring	NULL
only	NULL
one	NULL
or	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
elements	NULL
was	NULL
exam-ined	NULL
.	NULL

PBLs	NULL
and	NULL
MT4	NULL
cells	NULL
were	NULL
the	NULL
most	NULL
permissive	NULL
,	NULL
allowing	NULL
HIV	NULL
containing	NULL
only	NULL
a	NULL
single	NULL
NF-	NULL
«	NULL
B	NULL
motif	NULL
to	NULL
replicate	NULL
,	NULL
whereas	NULL
constructs	NULL
containing	NULL
one	NULL
or	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
elements	NULL
completely	NULL
failed	NULL
to	NULL
replicate	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

H9	NULL
and	NULL
CEM	NULL
cells	NULL
exhibited	NULL
an	NULL
intermediate	NULL
phenotype	NULL
:	NULL
replication	NULL
of	NULL
virus	NULL
with	NULL
a	NULL
single	NULL
NF-	NULL
«	NULL
B	NULL
sequence	NULL
was	NULL
restricted	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
but	NULL
HIV	NULL
containing	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
elements	NULL
was	NULL
infectious	NULL
in	NULL
two	NULL
of	NULL
two	NULL
experiments	NULL
in	NULL
H9	NULL
cells	NULL
and	NULL
one	NULL
(	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
of	NULL
three	NULL
experiments	NULL
in	NULL
CEM	NULL
cells	NULL
.	NULL

Vor	NULL
.	NULL

65	NULL
,	NULL
1991	NULL
NF-kB	NULL
RECONSTRUCTED	NULL
HIV	NULL
LTRs	NULL
4355	NULL
TATA	NULL
1	NULL
#	NULL
--	NULL
viRUS	NULL
DATE	NULL
(	NULL
S	NULL
)	NULL
OF	NULL
PRODUCTION	NULL
HARVEST	NULL
0/3	NULL
1/2	NULL
a25	NULL
2/2	NULL
d17	NULL
,	NULL
26	NULL
3/3	NULL
d17,26	NULL
,	NULL
27	NULL
1/2	NULL
a61	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Replication	NULL
of	NULL
HIV-1	NULL
proviruses	NULL
with	NULL
reconstructed	NULL
LTRs	NULL
containing	NULL
single	NULL
NF-	NULL
«	NULL
B	NULL
or	NULL
Spl	NULL
binding	NULL
motifs	NULL
following	NULL
transfection-cocultivation	NULL
.	NULL

The	NULL
structure	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
is	NULL
shown	NULL
diagrammatically	NULL
at	NULL
the	NULL
top	NULL
.	NULL

In	NULL
the	NULL
reconstructed	NULL
LTRs	NULL
,	NULL
a	NULL
filled	NULL
square	NULL
or	NULL
circle	NULL
indicates	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
individual	NULL
Spl	NULL
or	NULL
NF-kB	NULL
motif	NULL
,	NULL
respectively	NULL
.	NULL

NRE	NULL
denotes	NULL
the	NULL
negative	NULL
regulatory	NULL
element	NULL
.	NULL

The	NULL
frequency	NULL
of	NULL
virus	NULL
production	NULL
(	NULL
number	NULL
of	NULL
RT-positive	NULL
transfections-cocultivations	NULL
per	NULL
number	NULL
of	NULL
independent	NULL
experiments	NULL
)	NULL
and	NULL
the	NULL
day	NULL
of	NULL
virus	NULL
harvest	NULL
are	NULL
indicated	NULL
in	NULL
the	NULL
columns	NULL
on	NULL
the	NULL
right	NULL
.	NULL

To	NULL
assess	NULL
whether	NULL
the	NULL
LTRs	NULL
might	NULL
have	NULL
undergone	NULL
alteration	NULL
during	NULL
these	NULL
virus	NULL
infections	NULL
,	NULL
we	NULL
performed	NULL
``	NULL
RNA	NULL
PCR	NULL
``	NULL
on	NULL
the	NULL
genomic	NULL
RNAs	NULL
isolated	NULL
from	NULL
particular	NULL
samples	NULL
of	NULL
progeny	NULL
virions	NULL
.	NULL

These	NULL
samples	NULL
included	NULL
(	NULL
i	NULL
)	NULL
H9	NULL
cells	NULL
infected	NULL
with	NULL
HIV	NULL
y	NULL
;	NULL
;	NULL
,	NULL
;	NULL
(	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
no	NULL
Sp1	NULL
elements	NULL
)	NULL
,	NULL
(	NULL
ii	NULL
)	NULL
CEM	NULL
cells	NULL
infected	NULL
with	NULL
HIV	NULL
y	NULL
;	NULL
;	NULL
,	NULL
.	NULL

;	NULL
(	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
no	NULL
Spl	NULL
elements	NULL
)	NULL
,	NULL
and	NULL
(	NULL
iii	NULL
)	NULL
PBLs	NULL
infected	NULL
with	NULL
HIV	NULL
y	NULL
;	NULL
,	NULL
»	NULL
(	NULL
one	NULL
NF-kB	NULL
and	NULL
no	NULL
Spl	NULL
elements	NULL
)	NULL
.	NULL

The	NULL
resultant	NULL
amplified	NULL
cDNA	NULL
NF-xB	NULL
(	NULL
iI	NULL
)	NULL
__	NULL
Sp1	NULL
(	NULL
lit	NULL
)	NULL
was	NULL
cloned	NULL
,	NULL
and	NULL
the	NULL
5	NULL
'	NULL
445	NULL
bp	NULL
of	NULL
the	NULL
U3	NULL
portion	NULL
of	NULL
the	NULL
LTR	NULL
were	NULL
sequenced	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
the	NULL
original	NULL
deletions	NULL
generated	NULL
in	NULL
vitro	NULL
remained	NULL
intact	NULL
.	NULL

Furthermore	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
none	NULL
of	NULL
the	NULL
eight	NULL
cDNA	NULL
clones	NULL
derived	NULL
from	NULL
H9	NULL
cells	NULL
infected	NULL
with	NULL
pNL-2	NULL
«	NULL
B	NULL
contained	NULL
additional	NULL
changes	NULL
in	NULL
a	NULL
region	NULL
of	NULL
the	NULL
LTR	NULL
extending	NULL
from	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
elements	NULL
to	NULL
the	NULL
TATAA	NULL
site	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
8	NULL
of	NULL
10	NULL
PCR	NULL
clones	NULL
of	NULL
virus	NULL
recovered	NULL
from	NULL
CEM	NULL
cells	NULL
infected	NULL
with	NULL
HIV	NULL
yy	NULL
con	NULL
TATAA	NULL
_	NULL
Sp1	NULL
(	NULL
l	NULL
)	NULL
pNL4-3	NULL
ACAAGGGACT	NULL
TTCCGCTGGG	NULL
GACTTTCCAG	NULL
GGAGGCGTGG	NULL
CCTGGGCGGG	NULL
ACTGGGGAGT	NULL
GGCGAGCCCT	NULL
CAGATGCTGC	NULL
ATATAAG	NULL
PBL	NULL
1NFKB	NULL
...	NULL
...	NULL
...	NULL
A.T	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

PCR	NULL
analysis	NULL
of	NULL
a	NULL
portion	NULL
of	NULL
the	NULL
U3	NULL
region	NULL
of	NULL
HIV	NULL
LTR	NULL
mutants	NULL
lacking	NULL
Spl	NULL
binding	NULL
motifs	NULL
.	NULL

The	NULL
RNA	NULL
associated	NULL
with	NULL
the	NULL
cell-free	NULL
virus	NULL
emerging	NULL
from	NULL
H9	NULL
or	NULL
CEM	NULL
cells	NULL
infected	NULL
with	NULL
HIV	NULL
y	NULL
.	NULL

;	NULL
,	NULL
,	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
or	NULL
PBLs	NULL
infected	NULL
with	NULL
HIV	NULL
yi	NULL
.	NULL

;	NULL
,	NULL
;	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
was	NULL
reverse	NULL
transcribed	NULL
and	NULL
amplified	NULL
by	NULL
PCR	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
nucleotide	NULL
sequences	NULL
of	NULL
individual	NULL
clones	NULL
were	NULL
determined	NULL
and	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
the	NULL
parental	NULL
wild-type	NULL
HIV	NULL
»	NULL
;	NULL
,	NULL
.	NULL

;	NULL
shown	NULL
at	NULL
the	NULL
top	NULL
.	NULL

Identical	NULL
nucleotides	NULL
are	NULL
indicated	NULL
by	NULL
the	NULL
dots	NULL
;	NULL
dashes	NULL
denote	NULL
deleted	NULL
nucleotides	NULL
.	NULL

Nucleotide	NULL
substitutions	NULL
are	NULL
indicated	NULL
.	NULL

4356	NULL
ROSS	NULL
ET	NULL
AL	NULL
.	NULL

tained	NULL
a	NULL
C-to-T	NULL
change	NULL
at	NULL
nucleotide	NULL
-30	NULL
(	NULL
27	NULL
)	NULL
,	NULL
2	NULL
bp	NULL
upstream	NULL
from	NULL
the	NULL
TATAA	NULL
site	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
this	NULL
same	NULL
substitution	NULL
was	NULL
observed	NULL
in	NULL
all	NULL
10	NULL
clones	NULL
arising	NULL
from	NULL
the	NULL
PBL	NULL
infection	NULL
with	NULL
HIVnri	NULL
,	NULL
«	NULL
s	NULL
virus	NULL
and	NULL
was	NULL
accompanied	NULL
by	NULL
a	NULL
second	NULL
change	NULL
(	NULL
T	NULL
to	NULL
A	NULL
)	NULL
at	NULL
nucleotide	NULL
-32	NULL
in	NULL
8	NULL
of	NULL
these	NULL
10	NULL
clones	NULL
.	NULL

Some	NULL
of	NULL
the	NULL
amplified	NULL
LTR	NULL
clones	NULL
had	NULL
no	NULL
alterations	NULL
in	NULL
other	NULL
regions	NULL
of	NULL
the	NULL
LTR	NULL
;	NULL
in	NULL
the	NULL
others	NULL
examined	NULL
,	NULL
a	NULL
maximum	NULL
of	NULL
two	NULL
additional	NULL
changes	NULL
per	NULL
LTR	NULL
were	NULL
noted	NULL
,	NULL
none	NULL
of	NULL
which	NULL
were	NULL
clustered	NULL
in	NULL
a	NULL
specific	NULL
region	NULL
.	NULL

DISCUSSION	NULL
In	NULL
our	NULL
previous	NULL
studies	NULL
,	NULL
a	NULL
series	NULL
of	NULL
deletion	NULL
and	NULL
point	NULL
mutations	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
HIV	NULL
LTR	NULL
to	NULL
study	NULL
the	NULL
roles	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Spl	NULL
binding	NULL
sites	NULL
and	NULL
the	NULL
TAR	NULL
region	NULL
in	NULL
virus	NULL
production	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
did	NULL
not	NULL
render	NULL
the	NULL
resulting	NULL
proviral	NULL
DNA	NULL
replication	NULL
incompe-tent	NULL
.	NULL

The	NULL
removal	NULL
of	NULL
the	NULL
three	NULL
Spl	NULL
binding	NULL
sites	NULL
with	NULL
preservation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
<	NULL
B	NULL
binding	NULL
sites	NULL
resulted	NULL
in	NULL
a	NULL
virus	NULL
capable	NULL
of	NULL
replicating	NULL
in	NULL
human	NULL
PBLs	NULL
but	NULL
not	NULL
in	NULL
cells	NULL
lacking	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
simultaneous	NULL
excision	NULL
of	NULL
both	NULL
NF-kB	NULL
and	NULL
all	NULL
three	NULL
Spl	NULL
binding	NULL
sites	NULL
eliminated	NULL
the	NULL
capacity	NULL
of	NULL
HIV	NULL
to	NULL
replicate	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
observations	NULL
suggested	NULL
that	NULL
discrete	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
LTR	NULL
function	NULL
as	NULL
modular	NULL
units	NULL
,	NULL
called	NULL
enhansons	NULL
(	NULL
10	NULL
,	NULL
29	NULL
,	NULL
43	NULL
)	NULL
,	NULL
which	NULL
can	NULL
functionally	NULL
substitute	NULL
for	NULL
one	NULL
another	NULL
and	NULL
whose	NULL
importance	NULL
to	NULL
viral	NULL
replication	NULL
varies	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
depending	NULL
on	NULL
the	NULL
nature	NULL
of	NULL
cellular	NULL
transcriptional	NULL
factors	NULL
present	NULL
in	NULL
those	NULL
cells	NULL
.	NULL

In	NULL
the	NULL
present	NULL
studies	NULL
,	NULL
we	NULL
attempted	NULL
to	NULL
define	NULL
minimal	NULL
sequences	NULL
required	NULL
to	NULL
support	NULL
viral	NULL
replication	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
human	NULL
T	NULL
lymphocytes	NULL
and	NULL
further	NULL
characterized	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
enhansons	NULL
present	NULL
in	NULL
the	NULL
HIV	NULL
promoter-enhancer	NULL
sequences	NULL
.	NULL

Our	NULL
efforts	NULL
to	NULL
determine	NULL
minimal	NULL
promoter-enhancer	NULL
sequences	NULL
required	NULL
for	NULL
viral	NULL
replication	NULL
were	NULL
undertaken	NULL
using	NULL
a	NULL
reconstructive	NULL
approach	NULL
.	NULL

The	NULL
insertion	NULL
of	NULL
the	NULL
single	NULL
NF-KB	NULL
element	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
I	NULL
)	NULL
into	NULL
pNL-ZERO	NULL
was	NULL
sufficient	NULL
to	NULL
restore	NULL
HIV	NULL
replication	NULL
in	NULL
CEM-MT4	NULL
cocultures	NULL
;	NULL
in	NULL
contrast	NULL
,	NULL
NF-did	NULL
not	NULL
restore	NULL
replication	NULL
competence	NULL
.	NULL

In	NULL
analogous	NULL
LTR	NULL
reconstruction	NULL
experiments	NULL
involving	NULL
individual	NULL
Spl	NULL
motifs	NULL
,	NULL
a	NULL
continuum	NULL
of	NULL
replicative	NULL
capacities	NULL
was	NULL
observed	NULL
:	NULL
Sp1	NULL
(	NULL
III	NULL
)	NULL
>	NULL
Sp1	NULL
(	NULL
ID	NULL
)	NULL
>	NULL
Sp1	NULL
(	NULL
I	NULL
)	NULL
.	NULL

This	NULL
latter	NULL
result	NULL
is	NULL
consistent	NULL
with	NULL
reports	NULL
showing	NULL
that	NULL
the	NULL
Sp1l	NULL
(	NULL
I	NULL
)	NULL
element	NULL
has	NULL
lower	NULL
affinity	NULL
for	NULL
Spl	NULL
protein	NULL
(	NULL
20	NULL
)	NULL
and	NULL
for	NULL
factors	NULL
present	NULL
in	NULL
crude	NULL
nuclear	NULL
extracts	NULL
of	NULL
human	NULL
lymphocytes	NULL
(	NULL
35	NULL
)	NULL
than	NULL
does	NULL
either	NULL
element	NULL
II	NULL
or	NULL
III	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
HIV	NULL
preparations	NULL
containing	NULL
only	NULL
Sp1	NULL
(	NULL
III	NULL
)	NULL
to	NULL
infect	NULL
human	NULL
T	NULL
cells	NULL
is	NULL
currently	NULL
under	NULL
evaluation	NULL
.	NULL

As	NULL
neither	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
nor	NULL
Spl	NULL
binding	NULL
sites	NULL
are	NULL
absolutely	NULL
required	NULL
for	NULL
virus	NULL
replication	NULL
in	NULL
PBL	NULL
s	NULL
(	NULL
as	NULL
long	NULL
as	NULL
the	NULL
other	NULL
is	NULL
present	NULL
in	NULL
the	NULL
LTR	NULL
)	NULL
,	NULL
the	NULL
marked	NULL
conservation	NULL
of	NULL
the	NULL
presence	NULL
and	NULL
arrangement	NULL
of	NULL
these	NULL
two	NULL
types	NULL
of	NULL
cis-acting	NULL
sequences	NULL
in	NULL
all	NULL
known	NULL
HIV-1	NULL
isolates	NULL
is	NULL
puzzling	NULL
.	NULL

The	NULL
experiments	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
5	NULL
suggest	NULL
that	NULL
the	NULL
arrangement	NULL
and	NULL
spacing	NULL
of	NULL
adjacent	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Sp1	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
native	NULL
configuration	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
contribute	NULL
more	NULL
significantly	NULL
to	NULL
virus	NULL
replication	NULL
than	NULL
duplications	NULL
or	NULL
triplications	NULL
of	NULL
either	NULL
element	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
we	NULL
previously	NULL
reported	NULL
that	NULL
point	NULL
mutations	NULL
affecting	NULL
the	NULL
adjacent	NULL
NF-KB	NULL
and	NULL
Spl	NULL
elements	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
reduction	NULL
of	NULL
virus	NULL
replicative	NULL
capacity	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
two	NULL
independent	NULL
studies	NULL
suggest	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
functional	NULL
interaction	NULL
(	NULL
s	NULL
)	NULL
between	NULL
these	NULL
two	NULL
different	NULL
cis-acting	NULL
elements	NULL
and	NULL
the	NULL
proteins	NULL
whose	NULL
functions	NULL
they	NULL
mediate	NULL
.	NULL

Notably	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
are	NULL
frequently	NULL
situated	NULL
adjacent	NULL
to	NULL
binding	NULL
sites	NULL
for	NULL
constitutive	NULL
cellular	NULL
transcriptional	NULL
factors	NULL
.	NULL

One	NULL
striking	NULL
example	NULL
J.	NULL
Viror	NULL
.	NULL

is	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
cytomegalovirus	NULL
immediate-early	NULL
gene	NULL
,	NULL
in	NULL
which	NULL
a	NULL
series	NULL
of	NULL
NF-kB	NULL
binding	NULL
sites	NULL
are	NULL
interspersed	NULL
with	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
NF-1	NULL
(	NULL
12	NULL
,	NULL
16	NULL
)	NULL
.	NULL

When	NULL
these	NULL
elements	NULL
were	NULL
placed	NULL
adjacent	NULL
to	NULL
each	NULL
other	NULL
,	NULL
5	NULL
'	NULL
to	NULL
the	NULL
whey	NULL
acidic	NULL
protein	NULL
promoter	NULL
,	NULL
a	NULL
synergistic	NULL
enhancement	NULL
of	NULL
promoter	NULL
activity	NULL
was	NULL
observed	NULL
,	NULL
suggesting	NULL
that	NULL
in	NULL
this	NULL
context	NULL
,	NULL
NF-kB	NULL
was	NULL
able	NULL
to	NULL
interact	NULL
with	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
NF-1	NULL
site	NULL
to	NULL
augment	NULL
transcription	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
similar	NULL
studies	NULL
have	NULL
been	NULL
performed	NULL
to	NULL
study	NULL
the	NULL
interactions	NULL
between	NULL
adjacent	NULL
binding	NULL
sites	NULL
for	NULL
Spl	NULL
and	NULL
OTF-1	NULL
.	NULL

An	NULL
Spl	NULL
element	NULL
in	NULL
combination	NULL
with	NULL
a	NULL
high-affinity	NULL
OTF-1	NULL
site	NULL
augmented	NULL
transcription	NULL
2-fold	NULL
;	NULL
however	NULL
,	NULL
when	NULL
placed	NULL
next	NULL
to	NULL
a	NULL
low-affinity	NULL
OTF	NULL
site	NULL
,	NULL
the	NULL
Spl	NULL
site	NULL
increased	NULL
transcription	NULL
20-fold	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
as	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Spl	NULL
can	NULL
each	NULL
interact	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
to	NULL
augment	NULL
transcription	NULL
,	NULL
it	NULL
is	NULL
not	NULL
surprising	NULL
that	NULL
they	NULL
may	NULL
interact	NULL
with	NULL
each	NULL
other	NULL
in	NULL
the	NULL
HIV	NULL
LTR	NULL
to	NULL
promote	NULL
viral	NULL
replication	NULL
.	NULL

An	NULL
interesting	NULL
aspect	NULL
of	NULL
this	NULL
analysis	NULL
is	NULL
the	NULL
apparent	NULL
hierarchy	NULL
of	NULL
cellular	NULL
permissiveness	NULL
for	NULL
HIV	NULL
infection	NULL
seen	NULL
best	NULL
with	NULL
proviruses	NULL
containing	NULL
only	NULL
one	NULL
or	NULL
two	NULL
NF-kB	NULL
elements	NULL
.	NULL

The	NULL
order	NULL
observed	NULL
(	NULL
PBLs	NULL
=	NULL
MT4	NULL
>	NULL
H9	NULL
>	NULL
CEM	NULL
>	NULL
Jurkat	NULL
cells	NULL
)	NULL
is	NULL
consistent	NULL
with	NULL
our	NULL
previous	NULL
findings	NULL
(	NULL
PBLs	NULL
=	NULL
MT4	NULL
>	NULL
CEM	NULL
)	NULL
with	NULL
an	NULL
HIV	NULL
LTR	NULL
mutant	NULL
containing	NULL
a	NULL
wild-type	NULL
arrangement	NULL
of	NULL
NF-kB	NULL
motifs	NULL
but	NULL
lacking	NULL
all	NULL
three	NULL
Spl	NULL
sites	NULL
and	NULL
presumably	NULL
reflects	NULL
various	NULL
levels	NULL
of	NULL
cellular	NULL
factors	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
30	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
of	NULL
this	NULL
study	NULL
,	NULL
virus	NULL
containing	NULL
a	NULL
single	NULL
NF-kB	NULL
element	NULL
was	NULL
capable	NULL
of	NULL
infecting	NULL
PBLs	NULL
and	NULL
MT4	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
exclusively	NULL
.	NULL

At	NULL
the	NULL
other	NULL
extreme	NULL
,	NULL
HIV	NULL
with	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
elements	NULL
failed	NULL
to	NULL
replicate	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

This	NULL
continuum	NULL
of	NULL
cellular	NULL
susceptibility	NULL
was	NULL
also	NULL
reflected	NULL
in	NULL
the	NULL
number	NULL
and	NULL
types	NULL
of	NULL
second-site	NULL
revertants	NULL
which	NULL
appeared	NULL
during	NULL
infection	NULL
.	NULL

H9	NULL
cells	NULL
consistently	NULL
supported	NULL
replication	NULL
of	NULL
HIV	NULL
with	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
elements	NULL
;	NULL
progeny	NULL
virions	NULL
from	NULL
such	NULL
an	NULL
infection	NULL
contained	NULL
an	NULL
unaltered	NULL
LTR	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

This	NULL
same	NULL
virus	NULL
inoculum	NULL
produced	NULL
progeny	NULL
virions	NULL
in	NULL
only	NULL
one	NULL
of	NULL
three	NULL
independent	NULL
infections	NULL
of	NULL
CEM	NULL
(	NULL
A3.01	NULL
)	NULL
cells	NULL
.	NULL

PCR	NULL
analysis	NULL
revealed	NULL
a	NULL
consistent	NULL
second-site	NULL
mutation	NULL
in	NULL
8	NULL
of	NULL
10	NULL
cDNA	NULL
clones	NULL
arising	NULL
from	NULL
this	NULL
single	NULL
positive	NULL
experiment	NULL
that	NULL
was	NULL
localized	NULL
to	NULL
the	NULL
TATA	NULL
region	NULL
of	NULL
the	NULL
LTR	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
HIV	NULL
construction	NULL
with	NULL
a	NULL
single	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
(	NULL
NL-1	NULL
«	NULL
B	NULL
)	NULL
replicated	NULL
slowly	NULL
in	NULL
PBLs	NULL
but	NULL
,	NULL
in	NULL
the	NULL
process	NULL
,	NULL
acquired	NULL
two	NULL
changes	NULL
also	NULL
situated	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
.	NULL

Thus	NULL
,	NULL
a	NULL
selection	NULL
for	NULL
virions	NULL
containing	NULL
a	NULL
similar	NULL
TATA	NULL
mutation	NULL
is	NULL
operative	NULL
in	NULL
both	NULL
CEM	NULL
cells	NULL
and	NULL
PBLs	NULL
,	NULL
possibly	NULL
reflecting	NULL
the	NULL
40-bp	NULL
deletion	NULL
encompassing	NULL
the	NULL
three	NULL
Spl	NULL
sites	NULL
which	NULL
effectively	NULL
places	NULL
the	NULL
NF-kB	NULL
(	NULL
I	NULL
)	NULL
motif	NULL
13	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
.	NULL

This	NULL
TATA	NULL
alteration	NULL
is	NULL
consistent	NULL
with	NULL
reports	NULL
describing	NULL
the	NULL
restricted	NULL
interaction	NULL
between	NULL
a	NULL
cell-specific	NULL
enhancer	NULL
and	NULL
discrete	NULL
VIRUS	NULL
TATA	NULL
BOX	NULL
HILO	NULL
TVPE	NULL
TGCTGC	NULL
CEN	NULL
REVERTANT	NULL
memo	NULL
menus	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

TATA	NULL
box	NULL
revertants	NULL
which	NULL
appear	NULL
following	NULL
infection	NULL
of	NULL
CEM	NULL
and	NULL
activated	NULL
PBL	NULL
cells	NULL
with	NULL
HIV	NULL
containing	NULL
only	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
motif	NULL
(	NULL
s	NULL
)	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B/Spl	NULL
domain	NULL
.	NULL

PBL	NULL
REVERTANT	NULL
Vor	NULL
.	NULL

65	NULL
,	NULL
1991	NULL
TATA	NULL
sequences	NULL
(	NULL
39	NULL
,	NULL
42	NULL
,	NULL
44	NULL
)	NULL
.	NULL

Perhaps	NULL
the	NULL
alteration	NULL
of	NULL
the	NULL
wild-type	NULL
HIV	NULL
TATAA	NULL
box	NULL
to	NULL
TATATAA	NULL
is	NULL
necessary	NULL
for	NULL
functional	NULL
interaction	NULL
with	NULL
the	NULL
dislocated	NULL
NF-kB	NULL
element	NULL
(	NULL
s	NULL
)	NULL
.	NULL

It	NULL
is	NULL
worth	NULL
noting	NULL
that	NULL
the	NULL
base	NULL
change	NULL
common	NULL
to	NULL
both	NULL
second-site	NULL
revertant	NULL
viruses	NULL
extended	NULL
the	NULL
TATA	NULL
box	NULL
two	NULL
nucleotides	NULL
in	NULL
the	NULL
5	NULL
'	NULL
direction	NULL
relative	NULL
to	NULL
that	NULL
of	NULL
the	NULL
parental	NULL
virus	NULL
pNL4-3	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
TATA	NULL
element	NULL
positions	NULL
where	NULL
RNA	NULL
polymerase	NULL
II	NULL
initiates	NULL
RNA	NULL
synthesis	NULL
,	NULL
this	NULL
change	NULL
could	NULL
shift	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
from	NULL
its	NULL
normal	NULL
location	NULL
at	NULL
the	NULL
U3/R	NULL
border	NULL
.	NULL

Experiments	NULL
to	NULL
ascertain	NULL
whether	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
has	NULL
been	NULL
altered	NULL
in	NULL
the	NULL
LTR	NULL
revertant	NULL
viruses	NULL
and	NULL
to	NULL
assess	NULL
the	NULL
effects	NULL
of	NULL
such	NULL
TATA	NULL
changes	NULL
on	NULL
HIV	NULL
replication	NULL
are	NULL
presently	NULL
in	NULL
progress	NULL
.	NULL

ACKNOWLEDGMENT	NULL
The	NULL
following	NULL
reagent	NULL
was	NULL
obtained	NULL
from	NULL
the	NULL
AIDS	NULL
Research	NULL
and	NULL
Reference	NULL
Reagent	NULL
Program	NULL
,	NULL
Division	NULL
of	NULL
AIDS	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Diseases	NULL
:	NULL
Jurkat	NULL
clone	NULL
E6-1	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

REFERENCES	NULL
.	NULL

Adachi	NULL
,	NULL
A.	NULL
,	NULL
H.	NULL
E.	NULL
Gendelman	NULL
,	NULL
S.	NULL
Koenig	NULL
,	NULL
T.	NULL
Folks	NULL
,	NULL
R.	NULL
Willey	NULL
,	NULL
A.	NULL
Rabson	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Martin	NULL
.	NULL

1986	NULL
.	NULL

Production	NULL
of	NULL
acquired	NULL
immunodeficiency	NULL
syndrome-associated	NULL
retrovirus	NULL
in	NULL
human	NULL
and	NULL
nonhuman	NULL
cells	NULL
transfected	NULL
with	NULL
an	NULL
infectious	NULL
molecular	NULL
clone	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

59:284-291.	NULL
.	NULL

Ahmad	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
S.	NULL
Venkatesan	NULL
.	NULL

1988	NULL
.	NULL

Nef	NULL
protein	NULL
of	NULL
HIV-1	NULL
is	NULL
a	NULL
transcriptional	NULL
repressor	NULL
of	NULL
HIV-1	NULL
LTR	NULL
.	NULL

Science	NULL
241:1481-1485.	NULL
.	NULL

Arya	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
C.	NULL
Guo	NULL
,	NULL
S.	NULL
F.	NULL
Josephs	NULL
,	NULL
and	NULL
F.	NULL
Wong-Staal	NULL
.	NULL

1985	NULL
.	NULL

Trans-activator	NULL
gene	NULL
of	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
III	NULL
(	NULL
HTLV-III	NULL
)	NULL
.	NULL

Science	NULL
229:69-73.	NULL
.	NULL

Berkhout	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
K.-T.	NULL
Jeang	NULL
.	NULL

1989.	NULL
trans	NULL
activation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
is	NULL
sequence	NULL
specific	NULL
for	NULL
both	NULL
the	NULL
single-stranded	NULL
bulge	NULL
and	NULL
loop	NULL
of	NULL
the	NULL
frans-acting-responsive	NULL
hairpin	NULL
:	NULL
a	NULL
quantitative	NULL
analysis	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:5501-5504.	NULL
.	NULL

Berkhout	NULL
,	NULL
B.	NULL
,	NULL
R.	NULL
H.	NULL
Silverman	NULL
,	NULL
and	NULL
K.-T.	NULL
Jeang	NULL
.	NULL

1989	NULL
.	NULL

Tat	NULL
trans-activates	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
through	NULL
a	NULL
nascent	NULL
RNA	NULL
target	NULL
.	NULL

Cell	NULL
59:273-282.	NULL
.	NULL

Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
J.-P.	NULL
Shaw	NULL
,	NULL
M.	NULL
R.	NULL
Bush	NULL
,	NULL
R.	NULL
E.	NULL
Replogle	NULL
,	NULL
R.	NULL
Belagaje	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1988	NULL
.	NULL

Characterization	NULL
of	NULL
antigen	NULL
receptor	NULL
response	NULL
elements	NULL
within	NULL
the	NULL
interleukin-2	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:1715-1724.	NULL
.	NULL

Dynan	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1983	NULL
.	NULL

The	NULL
promoter-specific	NULL
tran	NULL
scription	NULL
factor	NULL
Spl	NULL
binds	NULL
to	NULL
upstream	NULL
sequences	NULL
in	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
.	NULL

Cell	NULL
35:79-87.	NULL
.	NULL

Feng	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
E.	NULL
C.	NULL
Holland	NULL
.	NULL

1988	NULL
.	NULL

HIV-1	NULL
tat	NULL
trans-activation	NULL
requires	NULL
the	NULL
loop	NULL
sequence	NULL
within	NULL
far	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
334	NULL
:	NULL
165-167.	NULL
.	NULL

Folks	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Benn	NULL
,	NULL
A.	NULL
Rabson	NULL
,	NULL
T.	NULL
Theodore	NULL
,	NULL
M.	NULL
D.	NULL
Hoggan	NULL
,	NULL
M.	NULL
Martin	NULL
,	NULL
M.	NULL
Lightfoote	NULL
,	NULL
and	NULL
K.	NULL
Sell	NULL
.	NULL

1985	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
continuous	NULL
T-cell	NULL
line	NULL
susceptible	NULL
to	NULL
the	NULL
cytopathic	NULL
effects	NULL
of	NULL
the	NULL
acquired	NULL
immunodeficiency	NULL
syndrome	NULL
(	NULL
AIDS	NULL
)	NULL
-associated	NULL
retro-virus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82:4539-4543	NULL
.	NULL

Fromental	NULL
,	NULL
C.	NULL
,	NULL
M.	NULL
Kanno	NULL
,	NULL
H.	NULL
Nomiyama	NULL
,	NULL
and	NULL
P.	NULL
Chambon	NULL
.	NULL

1988	NULL
.	NULL

Cooperativity	NULL
and	NULL
hierarchical	NULL
levels	NULL
of	NULL
functional	NULL
organization	NULL
in	NULL
the	NULL
SV40	NULL
enhancer	NULL
.	NULL

Cell	NULL
5§4:943-953	NULL
.	NULL

Garcia	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
D.	NULL
Harrich	NULL
,	NULL
E.	NULL
Soultanakis	NULL
,	NULL
F.	NULL
Wu	NULL
,	NULL
R.	NULL
Mitsuyasu	NULL
,	NULL
and	NULL
R.	NULL
B.	NULL
Gaynor	NULL
.	NULL

1989	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
LTR	NULL
TATA	NULL
and	NULL
TAR	NULL
region	NULL
sequences	NULL
required	NULL
for	NULL
transcriptional	NULL
regulation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:765-778	NULL
.	NULL

Ghazal	NULL
,	NULL
P.	NULL
,	NULL
H.	NULL
Lubon	NULL
,	NULL
B.	NULL
Fleckenstein	NULL
,	NULL
and	NULL
L.	NULL
Hennighausen	NULL
.	NULL

1987	NULL
.	NULL

Binding	NULL
of	NULL
transcription	NULL
factors	NULL
and	NULL
creation	NULL
of	NULL
a	NULL
large	NULL
nucleoprotein	NULL
complex	NULL
on	NULL
the	NULL
human	NULL
cytomegalovirus	NULL
enhancer	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:3658-3662	NULL
.	NULL

Guyader	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Emerman	NULL
,	NULL
P.	NULL
Sonigo	NULL
,	NULL
F.	NULL
Clavel	NULL
,	NULL
L.	NULL
Montagnier	NULL
,	NULL
and	NULL
M.	NULL
Alizon	NULL
.	NULL

1987	NULL
.	NULL

Genome	NULL
organization	NULL
and	NULL
transactivation	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
2	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
326:662-669	NULL
.	NULL

Harrich	NULL
,	NULL
D.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Garcia	NULL
,	NULL
R.	NULL
Mitsuyasu	NULL
,	NULL
and	NULL
R.	NULL
B.	NULL
Gaynor	NULL
.	NULL

1990	NULL
.	NULL

TAR	NULL
independent	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
immunodefi-	NULL
15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

RECONSTRUCTED	NULL
HIV	NULL
LTRs	NULL
4357	NULL
ciency	NULL
virus	NULL
in	NULL
phorbol	NULL
ester	NULL
stimulated	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:4417-4423	NULL
.	NULL

Harrich	NULL
,	NULL
D.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Garcia	NULL
,	NULL
F.	NULL
K.	NULL
Wu	NULL
,	NULL
R.	NULL
Mitsuyasu	NULL
,	NULL
J.	NULL
Gonzales	NULL
,	NULL
and	NULL
R.	NULL
B.	NULL
Gaynor	NULL
.	NULL

1989	NULL
.	NULL

Role	NULL
of	NULL
Spl-binding	NULL
domains	NULL
in	NULL
in	NULL
vivo	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:2585-2591	NULL
.	NULL

Hennighausen	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
B.	NULL
Fleckenstein	NULL
.	NULL

1986	NULL
.	NULL

Nuclear	NULL
factor	NULL
1	NULL
interacts	NULL
with	NULL
five	NULL
DNA	NULL
elements	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
human	NULL
cytomegalovirus	NULL
major	NULL
immediate	NULL
early	NULL
gene	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

5:1367-1371	NULL
.	NULL

Hennighausen	NULL
,	NULL
L.	NULL
,	NULL
P.	NULL
A.	NULL
Furth	NULL
,	NULL
and	NULL
C.	NULL
W.	NULL
Pittius	NULL
.	NULL

1989.	NULL
kB	NULL
elements	NULL
strongly	NULL
activate	NULL
gene	NULL
expression	NULL
in	NULL
non-lymphoid	NULL
cells	NULL
and	NULL
function	NULL
synergistically	NULL
with	NULL
NF1	NULL
elements	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:8197-8206	NULL
.	NULL

Jakobovits	NULL
,	NULL
A.	NULL
,	NULL
D.	NULL
H.	NULL
Smith	NULL
,	NULL
E.	NULL
B.	NULL
Jakobovits	NULL
,	NULL
and	NULL
D.	NULL
J.	NULL
Capon	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
discrete	NULL
element	NULL
3	NULL
'	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
and	NULL
HIV-2	NULL
mRNA	NULL
initiation	NULL
sites	NULL
mediates	NULL
transcriptional	NULL
activation	NULL
by	NULL
an	NULL
HIV	NULL
trans	NULL
activator	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:2555-2561	NULL
.	NULL

Janson	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
U.	NULL
Pettersson	NULL
.	NULL

1990	NULL
.	NULL

Cooperative	NULL
interactions	NULL
between	NULL
transcription	NULL
factors	NULL
Spl	NULL
and	NULL
OTF-1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:4732-4736	NULL
.	NULL

Jones	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
J.	NULL
T.	NULL
Kadonga	NULL
,	NULL
P.	NULL
A.	NULL
Luciw	NULL
,	NULL
and	NULL
R.	NULL
Tijan	NULL
.	NULL

1986	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
AIDS	NULL
retrovirus	NULL
promoter	NULL
by	NULL
the	NULL
cellular	NULL
transcription	NULL
factor	NULL
,	NULL
Spl	NULL
.	NULL

Science	NULL
232:755-759	NULL
.	NULL

Kawakami	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
Schneidereit	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1988	NULL
.	NULL

Identification	NULL
and	NULL
purification	NULL
of	NULL
a	NULL
human	NULL
immunoglobulin	NULL
enhancer-binding	NULL
protein	NULL
(	NULL
NF-kB	NULL
)	NULL
that	NULL
activates	NULL
transcription	NULL
from	NULL
a	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
promoter	NULL
in	NULL
vitro	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:4700-4704	NULL
.	NULL

Kunkel	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

1985	NULL
.	NULL

Rapid	NULL
and	NULL
efficient	NULL
site-specific	NULL
mutagenesis	NULL
without	NULL
phenotype	NULL
selection	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82:488-492	NULL
.	NULL

Leonard	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Parrott	NULL
,	NULL
A.	NULL
J.	NULL
Buckler-White	NULL
,	NULL
W.	NULL
Turner	NULL
,	NULL
E.	NULL
K.	NULL
Ross	NULL
,	NULL
M.	NULL
A.	NULL
Martin	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rabson	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
are	NULL
not	NULL
required	NULL
for	NULL
virus	NULL
infectivity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:4919-4924	NULL
.	NULL

Lu	NULL
,	NULL
Y.	NULL
,	NULL
M.	NULL
Stenzel	NULL
,	NULL
J.	NULL
G.	NULL
Sodroski	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1989	NULL
.	NULL

Effects	NULL
of	NULL
long	NULL
terminal	NULL
repeat	NULL
mutations	NULL
on	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
replication	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:4115-4119	NULL
.	NULL

Miyoshi	NULL
,	NULL
I.	NULL
,	NULL
H.	NULL
Taguchi	NULL
,	NULL
I.	NULL
Kubonishi	NULL
,	NULL
S.	NULL
Yoshimoto	NULL
,	NULL
Y.	NULL
Ohtsuki	NULL
,	NULL
F.	NULL
Shiraishi	NULL
,	NULL
and	NULL
T.	NULL
Akagi	NULL
.	NULL

1982	NULL
.	NULL

Type	NULL
c	NULL
virus-producing	NULL
cell	NULL
lines	NULL
derived	NULL
from	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
.	NULL

Gann	NULL
Monogr	NULL
.	NULL

28:219-228	NULL
.	NULL

Morgan	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
K.	NULL
Cornetta	NULL
,	NULL
and	NULL
W.	NULL
F.	NULL
Anderson	NULL
.	NULL

1990	NULL
.	NULL

Applications	NULL
of	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
in	NULL
retroviral-mediated	NULL
gene	NULL
transfer	NULL
and	NULL
the	NULL
analysis	NULL
of	NULL
gene-marked	NULL
human	NULL
TIL	NULL
cells	NULL
.	NULL

Hum	NULL
.	NULL

Gene	NULL
Ther	NULL
.	NULL

1:135-149	NULL
.	NULL

Myers	NULL
,	NULL
G.	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Rabson	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Berzofsky	NULL
,	NULL
T.	NULL
F.	NULL
Smith	NULL
,	NULL
and	NULL
F.	NULL
Wong-Staal	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

.	NULL

1990	NULL
.	NULL

Human	NULL
retroviruses	NULL
and	NULL
AIDS	NULL
1990	NULL
,	NULL
p.	NULL
I-A-64	NULL
.	NULL

Theoretical	NULL
Biology	NULL
and	NULL
Biophysics	NULL
,	NULL
Los	NULL
Alamos	NULL
National	NULL
Laboratory	NULL
,	NULL
Los	NULL
Alamos	NULL
,	NULL
N.Mex	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
326:711-713	NULL
.	NULL

Ondek	NULL
,	NULL
B.	NULL
,	NULL
L.	NULL
Gloss	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
SV40	NULL
enhancer	NULL
contains	NULL
two	NULL
distinct	NULL
levels	NULL
of	NULL
organization	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
333:40-45	NULL
.	NULL

Parrott	NULL
,	NULL
C.	NULL
,	NULL
T.	NULL
Seidner	NULL
,	NULL
E.	NULL
Duh	NULL
,	NULL
J.	NULL
Leonard	NULL
,	NULL
T.	NULL
S.	NULL
Theodore	NULL
,	NULL
A.	NULL
Buckler-White	NULL
,	NULL
M.	NULL
A.	NULL
Martin	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rabson	NULL
.	NULL

1991	NULL
.	NULL

Variable	NULL
role	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
Spl-binding	NULL
sites	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
replication	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:1414-1419	NULL
.	NULL

Popovic	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
G.	NULL
Sarnagadharan	NULL
,	NULL
E.	NULL
Read	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Gallo	NULL
.	NULL

1984	NULL
.	NULL

Detection	NULL
,	NULL
isolation	NULL
,	NULL
and	NULL
continuous	NULL
production	NULL
of	NULL
cytopathic	NULL
retroviruses	NULL
(	NULL
HTLV-III	NULL
)	NULL
from	NULL
patients	NULL
with	NULL
AIDS	NULL
and	NULL
pre-AIDS	NULL
.	NULL

Science	NULL
224:497-500	NULL
.	NULL

Rosen	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
J.	NULL
G.	NULL
Sodroski	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1985	NULL
.	NULL

The	NULL
location	NULL
of	NULL
cis-acting	NULL
regulatory	NULL
sequences	NULL
in	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
lymphotrophic	NULL
virus	NULL
type	NULL
III	NULL
(	NULL
HTLV-III/LAV	NULL
)	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Cell	NULL
41:813-823	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
F.	NULL
Fritsch	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1989	NULL
.	NULL

Molecular	NULL
4358	NULL
34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

ROSS	NULL
ET	NULL
AL	NULL
.	NULL

cloning	NULL
:	NULL
a	NULL
laboratory	NULL
manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
N.Y.	NULL
Sanger	NULL
,	NULL
F.	NULL
,	NULL
S.	NULL
Nicklen	NULL
,	NULL
and	NULL
A.	NULL
R.	NULL
Coulson	NULL
.	NULL

1977	NULL
.	NULL

DNA	NULL
sequencing	NULL
with	NULL
chain-terminating	NULL
inhibitors	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
74:5463-5467	NULL
.	NULL

Seidner	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rabson	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

Selby	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
E.	NULL
S.	NULL
Bain	NULL
,	NULL
P.	NULL
A.	NULL
Luciw	NULL
,	NULL
and	NULL
B.	NULL
M.	NULL
Peterlin	NULL
.	NULL

1989	NULL
.	NULL

Structure	NULL
,	NULL
sequence	NULL
,	NULL
and	NULL
position	NULL
of	NULL
the	NULL
stem-loop	NULL
in	NULL
tar	NULL
determine	NULL
transcriptional	NULL
elongation	NULL
by	NULL
tat	NULL
through	NULL
the	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:547-558	NULL
.	NULL

Shaw	NULL
,	NULL
J.-P.	NULL
,	NULL
P.	NULL
J.	NULL
Utz	NULL
,	NULL
D.	NULL
B.	NULL
Durand	NULL
,	NULL
J.	NULL
J.	NULL
Toole	NULL
,	NULL
E.	NULL
A.	NULL
Emmel	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1988	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
putative	NULL
regulator	NULL
of	NULL
early	NULL
T	NULL
cell	NULL
activation	NULL
genes	NULL
.	NULL

Science	NULL
241:202-205	NULL
.	NULL

Siekevitz	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
F.	NULL
Josephs	NULL
,	NULL
M.	NULL
Dukovich	NULL
,	NULL
N.	NULL
Peffer	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1987	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
by	NULL
T	NULL
cell	NULL
mitogens	NULL
and	NULL
the	NULL
frans-activator	NULL
protein	NULL
of	NULL
HTLV-1	NULL
.	NULL

Science	NULL
238:1575-1578	NULL
.	NULL

Simon	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
T.	NULL
M.	NULL
Fisch	NULL
,	NULL
B.	NULL
J.	NULL
Benecke	NULL
,	NULL
J.	NULL
R.	NULL
Nevins	NULL
,	NULL
and	NULL
N.	NULL
Heintz	NULL
.	NULL

1988	NULL
.	NULL

Definition	NULL
of	NULL
multiple	NULL
,	NULL
functionally	NULL
distinct	NULL
TATA	NULL
elements	NULL
,	NULL
one	NULL
of	NULL
which	NULL
is	NULL
a	NULL
target	NULL
in	NULL
the	NULL
Asp70	NULL
promoter	NULL
for	NULL
ElA	NULL
regulation	NULL
.	NULL

Cell	NULL
52:723-729	NULL
.	NULL

Sodroski	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Rosen	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
S.	NULL
Z.	NULL
Salahuddin	NULL
,	NULL
M.	NULL
Popovic	NULL
,	NULL
S.	NULL
Arya	NULL
,	NULL
R.	NULL
C.	NULL
Gallo	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1985	NULL
.	NULL

Trans-acting	NULL
transcriptional	NULL
regulation	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
III	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Science	NULL
227:171-173	NULL
.	NULL

Sodroski	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
R.	NULL
Patarca	NULL
,	NULL
and	NULL
42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

J.	NULL
Viror	NULL
.	NULL

W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1985	NULL
.	NULL

Location	NULL
of	NULL
the	NULL
trans-activating	NULL
region	NULL
on	NULL
the	NULL
genome	NULL
of	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
III	NULL
.	NULL

Science	NULL
229:74-77	NULL
.	NULL

Struhl	NULL
,	NULL
K.	NULL
1986	NULL
.	NULL

Constitutive	NULL
and	NULL
inducible	NULL
Saccharomyces	NULL
cerevisiae	NULL
promoters	NULL
:	NULL
evidence	NULL
for	NULL
two	NULL
distinct	NULL
molecular	NULL
mech-anisms	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

6:3847-3853	NULL
.	NULL

Tanaka	NULL
,	NULL
M.	NULL
,	NULL
U.	NULL
Grossniklaus	NULL
,	NULL
W.	NULL
Herr	NULL
,	NULL
and	NULL
N.	NULL
Hernandez	NULL
.	NULL

1988	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
U2	NULL
snRNA	NULL
promoter	NULL
by	NULL
the	NULL
octamer	NULL
motif	NULL
defines	NULL
a	NULL
new	NULL
class	NULL
of	NULL
RNA	NULL
polymerase	NULL
II	NULL
enhancer	NULL
elements	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

2:1764-1788.	NULL
.	NULL

Wefald	NULL
,	NULL
F.	NULL
C.	NULL
,	NULL
B.	NULL
H.	NULL
Deviin	NULL
,	NULL
and	NULL
R.	NULL
S.	NULL
Williams	NULL
.	NULL

1990	NULL
.	NULL

Func-	NULL
tional	NULL
heterogeneity	NULL
of	NULL
mammalian	NULL
TATA-box	NULL
sequences	NULL
revealed	NULL
by	NULL
interaction	NULL
with	NULL
cell-specific	NULL
enhancer	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
344:260-262	NULL
.	NULL

Weiss	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
R.	NULL
L.	NULL
Wiskocil	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Stobo	NULL
.	NULL

1984	NULL
.	NULL

The	NULL
role	NULL
of	NULL
T3	NULL
surface	NULL
molecules	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
:	NULL
a	NULL
two-stimulus	NULL
requirement	NULL
for	NULL
IL	NULL
2	NULL
production	NULL
reflects	NULL
events	NULL
occurring	NULL
at	NULL
a	NULL
pre-translational	NULL
level	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

133:123-128	NULL
.	NULL

Willey	NULL
,	NULL
R.	NULL
,	NULL
D.	NULL
H.	NULL
Smith	NULL
,	NULL
L.	NULL
A.	NULL
Lasky	NULL
,	NULL
T.	NULL
S.	NULL
Theodore	NULL
,	NULL
P.	NULL
L.	NULL
Earl	NULL
,	NULL
B.	NULL
Moss	NULL
,	NULL
D.	NULL
J.	NULL
Capon	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Martin	NULL
.	NULL

1988	NULL
.	NULL

In	NULL
vitro	NULL
mutagenesis	NULL
identifies	NULL
a	NULL
region	NULL
within	NULL
the	NULL
envelope	NULL
gene	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
that	NULL
is	NULL
critical	NULL
for	NULL
infectivity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

62:139-147	NULL
.	NULL

Zoller	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
M.	NULL
Smith	NULL
.	NULL

1983	NULL
.	NULL

Oligonucleotide-directed	NULL
mutagenesis	NULL
:	NULL
a	NULL
simple	NULL
method	NULL
using	NULL
two	NULL
oligonucleotide	NULL
primers	NULL
and	NULL
a	NULL
single-stranded	NULL
DNA	NULL
template	NULL
.	NULL

DNA	NULL
3:479-488	NULL
.	NULL

